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Abstract

Early events in the viral replication cycle of the human immunodeficiency
virus (HIV) determine the virus' ability to sustain a persistent infection in
susceptible host species. However, many of the molecular machinations through
which the virus progresses during its earliest moments in the cell's interior
remain enigmatic. Similar to other virus families, HIV virions are packed with a
specific assortment of viral and cellular proteins that allow them to carry out

their unique program for replication inside of target cells. One such protein that

is present in incoming virions, HIV-1 integrase, is an enzyme that facilitates the
fusion of the viral genome and the host genomic DNA in the nucleus, thereby
making HIV a permanent fixture in infected individuals. We have discovered

that, in addition to its role in catalyzing integration, the HIV-1 integrase plays
key part in transporting the viral DNA through the cytoplasm to the nucleus
during a process known as viral nuclear import. Viral nuclear import is a key

early step in the viral life cycle directly preceding integration that has to date

been exploited as a target for antiretroviral therapy. Our recent studies indicate
that a small stretch of sequence within the carboxyl terminus of the HIV-1
integrase protein contains a nuclear localization signal (NLS) that is
indispensable for viral nuclear import and therefore absolutely required for
productive HIV infection. Importantly, we have identified several mutations

ii

(NLS mutants) within this region that can disrupt nuclear import and therefore
completely stall HIV infection. In addition, alignment of all the known subtypes
of HIV within the region specified by our NLS mutants indicates that the virus
seldom changes its sequence in this part of its genome, suggesting that this
domain is a critical factor that it must preserve for optimal infection. Thus, a
major focus of this thesis is to clarify the role that the HIV integrase plays in
nuclear import. In turn, these analyses may provide a rational basis for the
design of new experimental drug screening systems dedicated to finding
inhibitors that block HIV-1 nuclear import and curtail HIV infection. A secondary

aim of this work is to understand the mechanism of species-specific restriction of
lentivirus infection in primates mediated by endogenous host cell restriction
factors such as Lvl/TRIM5-a. Lastly, a potential role for non-pathogenic viral
DNA episomal circles formed from integration-defective HIV virions as a novel
platform for gene therapy based vaccines is discussed.
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C h a p t e r i. I n t r o d u c t i o n

Background: Biology of HIV-1 Infection

I. HIV-1 natural history, phytogeny, and structural organization
The human immunodeficiency virus (HIV) belongs to a family of viruses called

the retroviridae, more specifically, to a subgroup known as lentiviruses. In 1983,
HIV was discovered to be the etiological agent of acquired immunodeficiency
syndrome (AIDS), a debilitating clinical condition which gradually erodes the
immune system leading to increased susceptibility to opportunistic infections,
and eventually, to death in infected patients. When HIV was first isolated by Luc
Montagnier, Franciose Barre-Sinousi, William Rozenbaum and colleagues at the
Pasteur Institute from a lymph node biopsy taken from a patient presenting the
early clinical symptoms of AIDS, and shown by Robert Gallo and colleagues at

the NCI to have reverse transcriptase activity (a hallmark of all retroviruses), i
became only the second retrovirus discovered to infect humans (the first being
the Human T-cell Leukemia Virus (HTLV I and II), whose discovery preceded
that of HIV by just three years) [1, 2]. At first, HIV was thought to represent a
new subtype of Human T-cell Leukemia virus, and was dubbed HTLV-III.
However, while these two human retroviruses both share a characteristic tropism

of CD4-bearing cells, they differ greatly in physical appearance, molecular
structure, and pathogenicity. It was later discovered that HIV more closely
resembles other known animal lentiviruses (including equine infectious anemia
virus EIAV, Visna virus, feline immunodeficiency virus FIV, and simian
immunodeficiency virus SIV) in structure, cell tropism, and replication kinetics

within infected cells [reviewed in [3, 4]]. These viruses, which derive their name
from the Latin term for slow ("lenti-"), accordingly cause chronic, persistent
infections that cause immune dysfunctions and neurological disorders in a
diverse array of animals including sheep, horses, cats and monkeys.
Consequently, the current global HIV epidemic is thought to have begun with a
zoonotic transmission of an SIV virus from a primate species in Central Africa
(most likely SIVcpz from chimpanzees) in an area where there is close contact
between humans and non-human primates. Indeed, there is a high prevalence of
these SIV viruses in feral populations of many African monkey species, including
those strains related to SIVcpz, which is believed to have entered humans via the
monkey butcheries found in locations where these animals are used as a food
source for the native human population [5]. Figure 1 shows the phylogenetic
relationships between the known SIV viruses and highlights the relatedness of
SYVcpz to the current HIV-1 virus responsible for the current AIDS pandemic.
Four different primate species are shown, rhesus macaques, chimpanzees,

humans, and owl monkeys, all of which have different susceptibilities to H I V
infection depending upon the endogenous retroviruses (which provide the basis

for the differentiation of host cell restriction factors like Lvl/TRIM5-(x) that t
naturally harbor. Incompatibility of cellular receptors for the virus envelope as
well as varying levels of innate immunity to immunodeficiency viruses may also
explain the differences in susceptibility to lentiviral infection among these
primate species.
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Figure 1. Natural history of H I V / S I V infection of primates. A ) A 650-bp pol fragment
w a s amplified from m o n k e y s representing seven different primate species, sequenced,
then subjected to phylogenetic tree analysis b y the neighbor-joining m e t h o d . T h e
positions of 21 SIV sequences (in color) are s h o w n in relation to H I V / S I V reference
sequences from the L o s A l a m o s H I V / S I V Sequence Database (in black). It is thought
that the current H I V p a n d e m i c e m a n a t e d from zoonotic transfer of such primate SIVs
f r o m practices such as b u s h m e a t butchery. B ) Pictures of a n o w l m o n k e y (Aotus
trivirgatus), rhesus m a c a q u e (Macaca mulatto), c h i m p a n z e e (Pan troglodytes), a n d h u m a n
( H o m o sapiens) are s h o w n . D e p e n d i n g o n the ancestral retroviruses that each of these
primate species harbor, they h a v e varying degrees of natural resistance to H I V or SIV
viruses d u e to the presence or absence of antiviral factors such as L v l / T R I M 5 - a l p h a .
[Adapted from reference 240].

II. Molecular biology of HIV-1 infection and pathogenesis
With a single-stranded, positive-sense 9.8 kilobase RNA genome, two copies
per virion, HIV shares many characteristics with other known retroviruses, such
as the presence of dedicated genes for structural (gag), enzymatic (pol), and
membrane targeting (env) activities. However, the specific molecular pathways
that HIV uses to infect its target cells are complex and enigmatic, and combined,
they enable the virus to do things that other retroviruses cannot, such as infect
non-dividing cells. The complexity of HIV replication cycle is undoubtedly the
result of the unprecedented number of genes, nine in total, that HIV specifies and
the plurality of functions that these viral gene products carry out within host

cells. In addition to the standard three retroviral genes (gag, pol, and env), the

genome encodes at least six other accessory genes (tat, rev, nef, vif, vpr, and vp
vpx), the most of any known retrovirus. Figure 2 shows the genetic organization
of the HIV-1 genome with the locations of the currently known viral proteins
indicated. As we gain more knowledge about the biological functions of all of
HIV viral gene products, specifically how they interact with each other and host

cell factors to promulgate productive infections with this virus inside of its tar
CD4+ cells, we will be better able to design new antiviral therapies to block its
replication and eradicate AIDS. HIV virions are typically 100 nanometers in
diameter and are indistinguishable from other lentiviruses under an electron

microscope. Their cone-shaped capsids contain the diploid viral genomic R N A
along with associated viral enzymes reverse transcriptase,

A.

ErwigistJty

Reverse
Transcriptase
Intr j i • :

100

n m

B.
PR
«••

FIT
L Z

1

1

11
II

gpl20

i 1

\
Vpu

1

CA

,„

I

VP,

gp41

[

1
\ Env

j Lin
J

Ne

N C p6

Figure 2. Virion structure a n d genetic organization of H I V - 1 . A ) A cross-section of a n
H I V virion w i t h the predicted location of all k n o w n viral proteins a n d phospholipid
bilayer s h o w n .

B ) T h e location of the long terminal repeats (LTRs) a n d the g e n e s

e n c o d e d b y H I V - 1 are indicated. G a g , Pol, a n d E n v proteins are initially synthesized as
polyprotein precursors. T h e G a g precursor is cleaved b y the viral protease (PR) into the

mature Gag proteins: matrix (MA, pl7), capsid (CA, p24), nucleocapsid (NC), and p6.
The GagPol precursor undergoes proteolytic processing to generate the Gag structural
proteins and the Pol enzymes: protease (PR, plO), reverse transcriptase (RT, p66/51) and
integrase (IN, p32). The Env glycoprotein precursor, gpl60, is cleaved by a cellular
protease during transport to the cell surface to generate the mature surface glycoprotein
gpl20 and the transmembrane glycoprotein gp41. The sizes of the genes and encoded
proteins are not drawn to scale. [Adapted from reference 239].

integrase, and protease. The viral capsid is surrounded by a phospholipids
bilayer whose outside is studded with trimeric clusters of the viral envelope
protein gpl60. Prior to its migration to the plasma membrane, the full-length
gpl60 polyprotein is cleaved by cellular proteases into two distinct subunits,
gpl20 (surface antigen, SU) and gp41 (transmembrane, TM), and these two
proteins form into non-covalently linked heterodimers which assemble into
stable trimeric complexes once at the virion surface. A brief description of each
the viral genes identified to date and overview of their proposed function(s) is
described below.

The H I V gag gene encodes a large 55 k D polypeptide which is cleaved by

the viral protease into four smaller proteins: the p24 capsid protein (CA), the pl
matrix protein (MA), p9 nucleocapsid (NC), and the p6 protein. This 55 kD
protein, often called the Gag precursor or Pr55, is myristylated at its amino
terminal end, which allows it to remain embedded in the cells phopholipid

bilayer at the interior cytoplasmic side while it is cleaved into p24, pl7, p9, an
p6 as the virions bud. Myristylation of the Gag precursor is required for the
production of viable virions and mutants which are defective for Pr55

myristylation fail to replicate [6]. As the myristylated Gag precursor accumulates
in increasing quantities at the plasma membrane, viral particles begin to form

and undergo the process of "budding" from the cell into m a n y discrete virions
[reviewed in [7]]. The full length viral genomic RNA is recruited to these
membrane localized Gag precursor assemblies through its interactions with NC,
which binds to the packaging sequence found in the 5' end of the RNA [8]. The
NC protein has also been shown to non-specifically bind RNA, and it is thought
that the diploid RNA strands encapsidated in the virion are afforded a protective
coating of NC protein.

As the viral particles bud from the plasma membrane, several viral proteins
are responsible for creating the mature infectious virions that attack new
uninfected cells. The most prominent of these is the HTV protease (PR) which

auto-catalytically releases itself, then cleaves the Gag-Pol precursor protein int
its active components MA, CA, NC, p6 and the viral enzymes reverse
transcriptase (RT) and integrase (IN), and more PR [reviewed in [9,10]]. The pl7
MA protein aids in the formation of mature infectious virions by stabilizing the
envelope protein at the plasma membrane through its binding of the cytoplasmic
tail of gp41 [11]. Recent results suggest a mechanism by which binding of the
gp41 cytoplasmic tail to Gag within immature HIV-1 particles inhibits Env
conformational changes on the surface of the virion that are required for proper
viral membrane fusion with target cells [12]. This "inside-out" regulation of HIV

-1 fusion could play an important role in the virus life cycle by preventing the
entry of immature, noninfectious particles [12].
Lastly, viral budding is completed by the membrane fission that is
mediated by the p6 protein from Gag. The p6 protein binds to a protein that is

normally involved in vesicular trafficking within cells called TsglOl [13-15]. The
p6 protein of HIV interacts with TsglOl via its PTAP motif (Pro-Thr-Ala-Pro) or
"late domain", and it is believed that this interaction allows the virions to bud
with the help of the ESCRT I complex (endosomal sorting complex required for
transport I (II and III)) which coordinates the multi-vesicular body pathway that
recycles endosomes during normal cellular metabolism [reviewed in [16-18]].
Thus, consistent with its role as an obligate intracellular parasite, HIV makes

efficient use of common cellular processes for sorting endosomes to facilitate its
release from infected cells. Once the immature virions are released from the cell
surface, the viral protease reaches a critical mass inside the budded virions and
increased proteolysis of Gag precursors causes the condensation and assembly of

p24 CA proteins that results in the structural formation of the mature virion core
A diagram of the complete HIV-1 life cycle is shown in Figure 3.
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Figure 3. Overview of the HIV-1 life cycle. A ) Electron micrographs of H I V
virions (blue) attacking a C D 4 + T cell (pink). B ) A schematic diagram of H T V replication
inside of an infected T cell is shown. Following attachment to the cell surface via C D 4 gpl20 binding /chemokine receptor engagement, envelope-mediated m e m b r a n e fusion
ensues.

After fusion, the virion core enters the cytosol and undergoes a series of

molecular interactions called "uncoating" and reverse transcription complexes (RTC)
form

allowing reverse transcription to occur.

During

or shortly after reverse

transcription, R T C bind cellular proteins such as H M G I(Y) and become pre-integration
complexes (PIC). PIC contain at a m i n i m u m IN, Vpr, and the viral D N A and are capable
of traversing the N P C and entering the nucleus, where integration occurs. The "early
phase" of the life cycle is complete after integration, then both full length and spliced
viral R N A

is transcribed, exported by Rev, translated by cellular machinery, and

assembled at the plasma m e m b r a n e facilitating the budding of n e w infectious virions.
[Adapted from reference 113].
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III. Regulation of the early events in the life cycle of HIV-1

As infection commences, HIV virions are drawn to the CD4+ molecules that
adorn the surface of T cells via the interaction with the CD4 binding domain of
gpl20. After CD4-gpl20 binding, the bound envelope protein undergoes a series
of conformational changes that allows it to bind chemokine receptor molecules

that are also present at the cell surface in these cells [19]. Generally, HIV reli
on either of two 7-transmembrane G-protein coupled chemokine receptors, CCR5
or CXCR4, as the co-receptor after CD4 engagement, but viruses that use other
chemokine receptors, such as CCR2b, have also been described [20].
Determinants within the variable loops of the gpl20 envelope protein dictate
which chemokine co-receptor the virus uses for entry, and a change in coreceptor usage from CCR5 to CXCR4 is associated with more rapid progression
to AIDS in chronically infected patients [20, 21]. Once chemokine receptor
binding has occurred, the gp41 transmembrane domain of HTV env achieves a
fusogenic state, which is marked by its insertion into the cell membrane and the

"zippering" of so called heptad repeat motifs that serve to bring the viral and ce
membranes into close proximity until membrane fusion occurs [22, 23].

After fusion of the viral and cell membrane has occurred, the HIV core
consisting of the p24 CA protein, the diploid viral RNA coated with the p9 NC
protein, along with the viral enzymes RT and IN, p6 and Vpr, enters into the

12

cytosol and a mysterious series of molecular events k n o w n as "uncoating"
ensues. The process of HIV-1 fusion and uncoating is depicted in Figure 4 below.
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Figure 4. H I V gp-120-CD4/co-receptor binding, fusion/entry, uncoating and PIC
formation. A) A schematic diagram of HIV envelope (gpl20/gp41) protein binding C D 4
on the surface of target cells, then exposure of the co-receptor binding site, binding to coreceptor (CCR5 or CXCR4), fusion peptide insertion into cell membrane, zippering of
heptad repeats, and resulting membrane fusion. B) Depiction of the early events of the
HIV life cycle immediately following viral fusion/entry. Upon entering the cytoplasm
of the infected cell, the virion core disassembles during "uncoating", presumably unless
blocked by the binding of host restriction factors (Lvl/TRIM5alpha) to the CA. Once
uncoating is finished, the virion reassembles into macromolecular structures for reverse
transcription (RTC) and nuclear import (PIC). These large sub-viral structures likely
containing host cell proteins (such as H M G I(Y)) and interact with cellular nuclear
import machinery in an unknown manner to cross the nuclear pore complex and
integrate into the host chromosomal D N A . [Adapted from ref 241].
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During uncoating, the p24 C A shell unravels and the remaining viral proteins
reorganize themselves to form specialized structures known as reverse
transcription complexes (RTCs) and pre-integration complexes (PICs) [reviewed
in [24-26]]. Certain cellular molecules may also be a part of these complexes and
they may bind to structural components of the cell such as actin filaments and
microtubules [26-28]. The precise composition of these sub-viral complexes has

been a matter of contention within the field, and a detailed discussion will follo
below. Suffice it to say, these intermediate complexes provide the context in
which reverse transcription occurs in the cytosol of the infected cell and it is
widely believed that the processes of uncoating and reverse transcription are
intricately coordinated.

All retroviruses specify an RT enzyme that allows them to convert their viral
RNA genomes into a double stranded viral DNA intermediate that serves as the

substrate for integration into the host genome. HIV is no different, and its RT is
an RNA- and DNA-dependent DNA polymerase that makes a cDNA copy of the
plus-stranded RNA genome from the incoming virion, then uses this cDNA as a
template for second-strand synthesis to make the full length double stranded
viral DNA ready for integration. The first step of HIV reverse transcription
begins when a lysine transfer RNA (tRNA) molecule binds to a stretch of
sequence near the 5' end of the genome known as the primer binding site (PBS)

15

[reviewed in [29-33]]. From this primer, R T synthesizes a short stretch of D N A ,
while degrading the copied RNA in the newly-formed RNA-DNA hybrid. Next,

by virtue of direct repeat regions located at each end of the viral RNA, this shor
stretch of newly synthesized cDNA can shift its hybridization from the 5' end to
the 3' end of the genomic RNA in a process known as "strand switching" or

"strand transfer." This allows the synthesis of a full-length minus strand and, in

the process, initiates the generation of the long-terminal repeats (LTR). There are
polypurine-rich regions (PPT) encoded within the genomic RNA that are
resistant to the RNase-H activity of reverse transcriptase. These regions prime
plus-strand DNA synthesis on the nascent minus-strand, and the central PPT has
been implicated in the enhancement of viral nuclear transport [34]. A second
strand-transfer is required to complete DNA synthesis. Successful initiation of
reverse transcription requires both the correct positioning of the amino-lysyltRNA primer at the PBS, as well as the relaxation of the secondary structure of
the viral RNA. The accessory protein Vif and the viral nucleocapsid (NC) assist
in the completion of these two vital processes [7, 35].

When reverse transcription has been completed, the viral genome has to
navigate through the viscous cytoplasmic milieu of the cell and somehow

translocate across the nuclear pore into the nucleus in order to access the host c
chromatin, where integration subsequently occurs. As the viral genome and the
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estimated

size of the sub-viral reverse transcription and

pre-integration

complexes exceeds the known 50 kD (25 nm) exclusion limit of the mammalian

cell nuclear pore [25, 36], it is unlikely that HIV nuclear import occurs by passi
diffusion. Indeed, the precise composition of the sub-viral complexes that HIV
forms once it enters the cytoplasm has been a topic of great contention and the
process of HIV nuclear import remains ill-understood. As nuclear import is a

key step in the early events of the viral life cycle and a major topic of this the
the composition of these sub-viral complexes and the proposed karyophilic

properties of the individual viral proteins will be discussed in more detail in th
sections to follow. After the viral DNA successfully localizes to the nucleus, it
targets chromosomal DNA where the viral IN enzyme catalyzes the insertion of
the HTV-1 genome into that of the host cell [37]. While it is widely held that
retroviral integration occurs at random spots on the host genomic DNA, recent
reports have suggested that HIV-1 displays a preference to insert its genome into
actively transcribed genes [reviewed in [38]]. The strand transfer reaction
catalyzed by the HIV IN allows the ends of the reverse transcribed viral DNA,
which have had two nucleotides removed by the enzyme's 3' processing activity,
to effect a nucleophilic attack of the chromosomal DNA, creating a gapped (at
each end) partially integrated intermediate. This gapped integration
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intermediate is thenfilledin by host D N A repair enzymes [39], and the fully
integrated retroviral DNA is called the provirus.

Once in the nucleus, an alternative fate of the viral DNA is also possible
that allows for the covalent fusing of the viral DNA ends by enzymes involved in
the non-homologous DNA end joining pathway, resulting in the circularization
of the HIV genome [40]. These covalently closed circular viral DNA
intermediates are called 1- and 2-LTR circles, and they were previously thought
to be labile byproducts of failed HIV integration attempts. However, these viral

episomes have unusual properties, such as their longevity inside of infected cells
and their ability to express limited quantities of certain early viral genes, and
Chapter 4 of this thesis highlights their potential use in gene therapy settings.
While these 2-LTR circles appear capable of expressing small quantities of HIV
Tat and Nef [reviewed in [41] and [42]], they are unable to sustain a productive
infection in HIV permissive cells and they do not cause overt toxicity.

Although unintegrated viral DNA templates are capable of driving limited
viral gene expression, the vast majority of HIV protein expression following

integration and formation of the proviral state is the result of active transcript
from the integrated viral DNA template. As the topic of this thesis involves the

early events of the viral life cycle that precede the transcription of viral genes

these steps of the viral life cycle will be discussed briefly below. In the integr
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H I V template, the 5'LTR serves as the major promoter-enhancer for viral gene
expression. The 5' LTR sequence possesses several regions (also present in the 3'
LTR) that are recognized by common cellular transcription factors such as NFkB,
Spl, NFAT-1, and Ap-1 as well as a defined TATAA box. The defined unit that

serves as the 5'LTR promoter includes a trio of binding sites for the constitutiv
expressed transcription factor Spl, followed by the TATAA box and the
transcription initiator element. Despite the presence of these transcriptional
elements, the 5'LTR is in general a weak promoter of viral gene expression on its
own [reviewed in [43]]. However, the presence of the transactivator protein (Tat),
and its subsequent binding to the transactivation response (TAR) element, a 59nucleotide stem-loop structure specified by the R region of the LTR [44],
dramatically increases the effectiveness of the 5'LTR promoter, and viral gene
expression following Tat-TAR complex formation increases one thousand-fold or
more [45]. The Tat-TAR complex acts in concert with the cellular factor cyclin T,
which recruits the cyclin-dependent kinase CDK9 to assemble the positive

elongation factor b (pTEF-b) complex at the transcriptional start site of the vira
template [46]. Recruitment of the pTEF-b containing the CDK9 kinase results in
the hyper-phosphorylation of RNA polymerase II, allowing it to firmly attach
and stimulate transcriptional elongation to form the viral RNA transcripts. As is
the case for the transcription factors NFkB and NFAT-1, both cyclin T expression
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and pTEF-b complex activity are up-regulated in activated T cells [reviewed in
[47]], reinforcing the notion that HIV enjoys a transcriptional advantage in these
cells which may at least in part explain the virus' selection of this compartment
as the major site for its replication.

Both unspliced and multiply-spliced viral RNAs are transcribed from the
integrated provirus. As the cell tends to retain incompletely-spliced, introncontaining mRNAs in the nucleus, HIV developed a system to ensure that its full
length unspliced genomic RNA and partially-spliced RNA transcripts can make
it to the cytosol. The viral Rev protein binds to a cis-acting RNA element called
the Rev-response element (RRE) that interacts with the cell's nuclear export
machinery to shuttle unspliced or partially spliced viral RNA out of the nucleus
and into the cytoplasm [48]. Rev itself is imported to the nucleus from the

cytoplasm via direct interaction of its nuclear localization signal with the solub
nuclear import receptor karyopherin 3 [49]. As Rev and the unspliced RREbearing viral RNA accumulates in the nucleus, the nuclear export karyopherin,
Crml (chromosome region maintenance protein 1) attaches to the Rev-RRE-RNA
complex along with RanGTP and actively transports the viral RNA through the
nuclear pore complex where it gains access to the cytosol. Once in the cytosol,
the cellular protein RanGAPl stimulates the hydrolysis of the attached RanGTP
to RanGDP, and the exported viral RNA is released into the cytoplasm, where it
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is free to attach to the Gag proteins that accumulate on the cytoplasmic side of
the cell's plasma membrane during virion assembly as described above.

Composition and Karyophilic Properties of the H I V Pre-integration Complex (PIC)
The nucleus is the largest membrane bounded compartment within
eukaryotic cells, and a substantial amount of cellular energy is devoted to the
shuttling of protein and ribonucleoprotein complexes through the nuclear pore
complex (NPC)—the negotiable gate between the nuclear cytoplasmic
compartments. After fusion and entry of its target cells, the Human
Immunodeficiency Virus (HIV-1) must navigate its genome through the cytosol
to the NPC and then into the nucleus where integration into the hosf s
chromosomal DNA subsequently occurs [50, 51]. Although this property is
essential to the virus' ability to infect its target cells, neither the precise

mechanism of its nuclear import nor the identity of the cellular factors and viral
determinants that are essential for it have been deciphered. For HIV-1, the study
of this process is not only of immense academic interest, but also of significant
medical relevance, as its clarification could lead to new therapeutic targets and
novel treatments for HIV disease.
It has long been known that the viral genome is contained in a large
nucleoprotein complex during reverse transcription of the viral RNA into its
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cognate D N A c o p y — a process that appears to be complete before viral nuclear

entry. This assembly of viral and host constituents is operationally defined as th
pre-integration complex, or PIC [26]. The PIC is capable of traversing the
cytoplasm, entering the nucleus, and targeting host chromatin. Once in the

nucleus, the viral integrase protein (IN), assisted by the action of host enzymes,

catalyzes the insertion of viral DNA into that of the host and subsequent repair o
the chromosomal interruptions created by the integration event.
The PIC, and the reverse transcription complexes that precede it in the

viral life cycle, likely constitute a series of structural and functional intermed
with changing composition. In fact, a variety of nucleoprotein complexes having
different sedimentation velocities have been isolated from the cytoplasm and
nucleus at specific times post-infection [52]. Not surprisingly, attempts to
characterize the viral and cellular protein components of PICs using biochemical
approaches have yielded disparate results. Integrase is consistently found as a
constituent of the PIC, as would be expected for a viral protein that performs
obligate catalyses on the viral DNA substrate in both the cytoplasm and nucleus.
Other PIC-associated viral proteins include matrix (MA), Vpr, and, less

frequently reported, nucleocapsid, capsid, and reverse transcriptase (RT) [26, 36,

53,54].
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A facilitating role in the nuclear import of the viral genome has been
attributed to a number of PIC components, including MA, Vpr, IN, and elements
in the viral DNA itself. Nevertheless, assignment of the relative importance of
each remains controversial. While some studies have implicated MA as a
mediator of infection in non-dividing cells [55, 56], others have shown that
infection with viruses that are altered in MA proceeds efficiently in the absence
either proposed karyophilic determinants within MA [57-59] or the majority of
the MA protein [60]. In addition, while the ability of Vpr to interact with the
nuclear pore complex has been well documented [61, 62], and varying degrees of
block to viral replication have been observed in its absence [63, 64], virions
lacking both Vpr and the proposed NLS regions in MA can still efficiently infect
non-dividing cells [54, 59]. Recent studies using confocal and electron
microscopy to visualize the fine structure of HTV reverse transcription complexes
(RTCs), a conglomerate that is believed to be a substructure of the PIC, confirmed
the presences of Vpr and IN within RTCs at 3 to four hours post infection with
VSV-pseudotyped HIV vectors [25].
A role in PIC nuclear import has also been attributed to the central DNA
flap—a discontinuity of the plus-strand of the HIV genome consisting of a 99

basepair region of triple helix viral DNA, which apparently acts in cis to enhance
nuclear targeting of the incoming PIC [65]. Viruses lacking this central DNA flap
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are not compromised for reverse transcription, but exhibit a slight 2-5 fold defect
in nuclear import [34]. Addition of the central DNA flap synthesis in lentiviral
vectors that normally lack the structure increases their ability to transduce a
variety of cell and tissue types in vitro [34] and in vivo [66]. However, recent
experiments suggest viruses lacking the central DNA flap exhibit near wild-type
levels of nuclear uptake under a variety of experimental conditions, and the

effects of this viral structure on nuclear import may be cell type-specific and le
significant than originally thought [67, 68].
The final PIC component with reported karyophilic activity is integrase.

Although an initial study characterized the intracellular localization of an IN-pgalactosidase fusion protein as cytoplasmic [69], further work using both
transient transfection and in vitro nuclear import assays has shown that IN
localizes predominantly to the nucleus [70-73]. One study reported that the
mutations K186Q and Q214LQ216L prevent the import of isolated IN or of other
PIC-associated proteins (and presumably of the PIC itself) in assays performed in
vitro [54], however, others have observed wild-type accumulation of nuclear
forms of viral DNA in the presence of these mutations [70, 74-76]. In a more
recent study, a peptide spanning amino acids 161-173 of IN was reported to act as
a transferable NLS. Mutations at residues V165 and R166 abrogated the nuclear
localization of an IN-pyruvate kinase fusion protein and, in the context of
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infection, impaired the accumulation of viral D N A in the nuclei of both dividing
and non-dividing cells [77]. Again, the interpretation of these results has been
challenged [78] and reassessed, and it was discovered that the V165 and R166

mutations have pleiotropic effects on the early viral life cycle (generally at the
step of reverse transcription) which overshadow their previously described
defects in nuclear import [67]. Thus, the precise mechanism of HIV nuclear entry,
as well as the identity of the cellular factors and viral determinants that are
essential for it, remains elusive.
Cellular proteins that have been associated with the PIC include the high
mobility group protein HMG I(Y) and another protein called barrier to autointegration factor 1 (BAF). HMG I(Y) is believed to bind to the reverse
transcribed viral DNA contained in the PICs and may facilitate the histone-like
winding and "coiling" of the PIC DNA, reducing its size from the approximated
3.3 microns if it were unwound, to the 56 nm estimated diameter of the PIC
[reviewed in [28, 79]. The BAF protein is thought to prevent the viral DNA from

integrating into itself in an intramolecular fashion and can enhance the catalytic

activity of salt-stripped PICs in vitro, though it is unclear whether this molecul

directly associated with the incoming PIC and its relative importance to the viral
life cycle is unknown[80]. Other proteins reported to associate with the incoming
PIC include chromatin remodeling proteins such as SNF5 (INI-1) and PML [81].
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Nuclear Import Overview
I. Structural features and functional relevance of the nuclear pore complex (NPC)

The mammalian cell nucleus is a key adaptation that marks the evolutionary
divergence of eukaryotic cells from lower level organisms. Accordingly, a
substantial amount of cellular energy is devoted to the shuttling of protein and
ribonucleoprotein complexes into and out of the nucleus, through the nuclear
pore complex (NPC)—the negotiable gate between the nuclear and cytoplasmic
compartments. While the nucleus appears to be a bounded compartment under
the light microscope, under the electron microscope it appears dotted with
numerous holes, which are the nuclear pore channels. An electron micrograph of
a mammalian cell nucleus is shown in Figure 5 along with a higher magnification
image of nuclear pores from an amoeba (dictyostelium discoideum). The outer
nuclear membrane is contiguous with the endoplasmic recticulum (ER)
membrane, while the inner nuclear membrane encapsulates the host cell
chromatin. The points at which these two membranes meet and interconnect are
the junctions where nuclear pores form [shown in Figure 6], giving rise to the
avenues of molecular transport between the cytoplasm and the nucleoplasm that
the NPC governs.
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Figure 5. Electron micrographs of the fine structure of the vertebrate N P C . A ) Cryoelectron micrograph of a mammalian cell with visible nuclear pores (black circles). B)
Electron micrograph N P C from a soil-dwelling amoeba, Dictyoselium discoideum, with
views from both the cytoplasmic and nuclear side of the N P C indicated (diagram). The
eight-fold symmetry of the N P C is clearly apparent. [Adapted from ref 242].
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Figure 6. Diagram of the Nuclear Pore Complex (NPC). A ) The N P C allows passive
diffusion of ions and small molecules. Nuclear proteins, RNAs, and ribonucleoprotein
(RNP) particles larger than ~9nm are selectively and actively transported through N P C s
by a signal-mediated and energy-dependent mechanism called nuclear import. B)
Surface renderings of the nuclear pore complexes revealing the central framework,
w h i c h exhibits strong 8-fold s y m m e t r y a n d thus consists of t w o identical halves relative
to the central plane of the nuclear envelope. [Adapted from references 4 3 a n d 44].
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Structurally, the N P C is immaculate in its design—a macromolecular structure of
over 125 mega Daltons composed of constant as well as static constituent
proteins that interact dynamically to govern traffic into and out of the cell
nucleus. The basic structure and function of the NPC has been preserved
throughout its evolution, with a high degree of homology evident between yeast
(the first cells to develop a distinct nucleus) and higher eukaryotic cells [82].
mammalian NPC is comprised of a set of at least 30 different proteins,
collectively termed nucleoporins [83]. The NPC displays eight-fold rotational
symmetry, therefore every nucleoporin is present at a copy number of either 8 or
an integer multiple of 8 [82, 84]. These proteins often contain amino acid
sequence motifs of phenylalanine and glycine dipeptide repeats (FG repeats),
which are believed to mediate the main interactions between nucleoporins and
the soluble transport receptors that carry out nuclear transport.
When viewed from the top-down, the nuclear pore looks like a wagon wheel
with eight spokes, each at a 45-degree angle. Indeed, phenylalanine-glycine
dipeptide repeats or variations thereof (i.e. GLFG or FXFG) are present in nearly
half of all of the nucleoporins identified, leading to the commonly used
nomenclature for them as "FG nups." These FG nups come in numerous shapes
and sizes. Some are long, filamentous proteins with multiple domains and
enzymatic activity, such as the cytosolic Nup358. Others line the core of the
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central channel and are more compact, such as Nup62. Regardless of their shape
or size, the FG nups that comprise the NPC are all oriented with their FG repeats
facing the interior of the nuclear pore channel, forming a pathway of FG repeats
for soluble nuclear import factors, such as the karyopherins (also called

importins), to interact with as they transport their cargo across the nuclear pore
The precise mechanism for FG nup-mediated nuclear translocation is unknown,
however several models have recently been proposed to explain this
phenomenon. Nuclear translocation occurs against a concentration gradient, and
kinetic studies have indicated that a single NPC can accommodate a mass flow of
up to 80 million Daltons per second, corresponding to about 1000 translocation
events per second per NPC [reviewed in [85]].
One model of nuclear translocation that has been proposed is the "Brownian
Affinity Gating" model [86]. This model suggests that a given polypeptide
moving in a rapid and random fashion through the cytolsol must pay an entropic
price for gaining access to the central channel of the nuclear pore, and, once
there, remains in a 'transition state' for nuclear translocation [86]. The larger

protein, the higher the entropic penalty for its gaining access to this transition
state, and the lower its probability to passively diffuse through the NPC. For

large proteins, active transport across the NPC is mediated by the interactions of
the FG nups (which line the interior of the NPC and stretch from the cytosolic to
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the nuclear compartments of the pore) with soluble transport factors that bind to
NLS containing large proteins, acting in a concerted 'enzymatic' fashion to help
the large proteins overcome the entropic barrier to nuclear translocation.
Another model is the hydrophobic exclusion or "selective gate" model [87].
This model suggest that the FG nups which line the central channel of the
nuclear pore create a hydrophobic environment that acts as a barrier to keep
large, hydrophilic proteins out. Macromolecules containing NLS sequences, and
therefore bound by soluble import factors such as the karyopherins would be
chaperoned across the pore by locally disrupting the hydrophobic "gate",

creating a selective partition for the molecule to pass through [87, 88] . A major
difference between the Brownian affinity gating and the hydrophobic selective

gate theories is that the latter calls for weak interactions between the FG repeat
themselves, while the former suggest that the FG repeats bind only to the
karyopherin-bound cargo proteins that are being imported. In yet another
proposed scenario, called the affinity gradient model, the FG nups are assembled

as an array of interaction sites with progressively increasing affinities from the

cytoplasmic to the nuclear sides of the NPC [89]. In this model, selective nuclear
transport is ensured because non-karyopherin-bound cargo proteins would be
unable to interact with FG nups and therefore would not undergo the cycles of
association/dissociation with the nucleoporins lining the central channel and
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would not be transported across the N P C .

A shematic diagram of these

proposed models of nuclear-cytoplasmic transport is shown in Figure 7.

17. Soluble transport receptors and the Ran GTPase system
For molecules that are too large to passively diffuse through the NPC,
nuclear-cytoplasmic transport begins with the recognition and binding of such

proteins by soluble transport receptors in the cytosol. Once these protein 'cargos
are bound by soluble transport receptors, the entire complex localizes to the
nuclear compartment where it docks at the NPC [reviewed in [90, 91]]. These

soluble transport receptors are called karyopherins (also referred to as importins
exportins and transportins) and they have the unique ability to bind to protein
cargos that display a specific amino acid sequence, known as a nuclear
localization signal (NLS) or nuclear export signal (NES), that determines the
directionality of their transport through the NPC. Fourteen different
karyopherins have been identified in the yeast S. cerevisiae, and at least 20 are

estimated to exist in vertebrates, each with the potential to recognize a differen
NLS or NES [reviewed in [92]]. In addition, these karyopherins often exist in a
and 3 isoforms, which form any number of different heterodimeric complexes
capable of binding to different FG nuceloporins in the NPC.
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Figure 7. Models of nuclear-cytoplasmic transport across the N P C . Schematic
diagrams of the three leading proposed models for h o w nuclear transport occurs across
the N P C are shown. A ) The "oily spaghetti" model suggests that a karyopherin-cargo
protein complex slides through a network of filamentous F G nucleoporins that normally
excludes macromolecules that d o not directly interact. These interactions m a y facilitate
r a n d o m m o v e m e n t of the karyopherin-cargo protein complex through the network of
F G nups and ultimately across the N P C . B) The "hydrophobic exclusion" model
proposes that the F G nups lining the central pore support w e a k hydrophobic
interactions between one another that creates a barrier of hydrophobicity that nonkaryopherin bound proteins will be unable to cross. C ) The "Brownian motion/Affinity
gating" model suggests that the F G nups m a y provide a series of sequential binding
sites of increasing affinity from the exterior to the interior of the N P C to which the
translocating karyopherin-cargo protein complexes temporally attach. F G binding sites
at the N P C faces create a high concentration of transport complexes near the N P C ,
increasing the probability that the translocating protein complexes will m o v e across it b y
random diffusion. [Adapted from reference 112].
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Generally, it is thought that the karyopherin a molecules bind to the N L S
containing cargo proteins, recruiting the karyopherin 3 molecules to form a
transport complex of the three proteins—kapcx/kapP+NLS-containing cargo
protein—which travels to the nucleus and crosses the nuclear pore through
interactions with the FG nucleoporins that comprise the NPC.
A small polypeptide known as Ran acts as a master regulator during nuclear
import through its enzymatic conversion of GTP GDP, forming an energetic
gradient across the pore [93]. In Figure 8a, a schematic model of the proposed
mechanism of karyopherin-mediated nuclear-cytoplasmic transport is shown.
Ran directly binds to karyopherins and acts as a molecular switch regulating
karyopherin association / disassociation with cargo and constituent molecules of
the NPC [reviewed in [90]].
During import, RanGTP binding to NLS-karyopherin complexes triggers
cargo release in the nucleus, whereas for export, RanGTP stabilizes the
karyopherin-cargo interaction, allowing the complex to exit across through the
NPC [92]. A steep RanGTP/RanGDP gradient has been measured across the

nuclear envelope and is key for dictating the directionality of transport [94]. Th
gradient is maintained by several essential Ran co-factors, such as RanGAPl,
RCC1, and NTF2.
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Figure 8. Soluble transport receptors and the RanGTPase system. Nuclear import is
carried out by soluble nuclear translocating receptors called karyopherins (also called
importins or exportins) in conjunction with an energetic gradient of G T P hydrolysis
catalyzed byt the small GTPase Ran. A) A schematic diagram of Ran-mediated
karyopherin-assisted nuclear import is shown. A given cargo protein (light blue)
bearing a functional N L S is bound by a complex of karyopherin alpha and beta (dark
blue). The cargo protein complex is then shuttled through the central channel of the
nuclear pore complex via the interactions of the bound karyopherins with the F G
nucleoporins (purple) that comprise the NPC. Once inside the nucleus, the karyopherinbound cargo protein binds to RanGTP (red triangle) in the nucleus causing it to be
released into the nucleus and allowing the unbound karyopherin complex to be recycled
to the cytosol after RanGAP-mediated RanGTPRanGDP hydrolysis. B) R a n G D P (pink)
is then recycled to the nucleus by a molecule called N T F 2 and is reloaded with G T P by
RanGEF to begin another import cycle. [Adapted reference 111].
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R a n G A P l , is the GTPase activating protein of Ran and it is found in on the
cytoplasmic side of the NPC, where it greatly enhances Ran's inherent GTPase
activity [95]. In the nucleus, the Ran guanine nucleotide exchange factor, RCC1,
helps Ran trade GTP for GDP [96]. The activity of RanGAPl and RCC1 set up
the RanGTP/RanGDP gradient across the NPC by maintaining a high
concentration of RanGTP in the nucleus and a low concentration of RanGTP in
the cytosol. Ran itself is rapidly shuttled into and out of the nucleus via
interactions with exporting karyopherins and a small (lOkD) Ran binding protein
called NTF2. NTF-2 binds to the GDP-bound form of Ran in the cytosol and
relocalizes it to the nucleus through its interactions with the FG nups that line
NPC. RCC1 is associated with nuclear chromatin, and RCC1 mediated
GTP GDP nucleotide exchange in this compartment causes the dissociation of
NTF2-RanGDP, freeing up more Ran to bind GTP in the nucleus. While Ran is
small enough (24kD) to passively diffuse across the NPC into the nucleus, NTF2assisted active transport of RanGDP enhances its import efficiency and ensures
the proper distribution of Ran between the cytoplasm and nucleus [97]. For
larger cargo protein cargos, there may be additional requirements for the
RanGTPase system [98].
While Ran-independent mechanisms for NPC transport have been suggested
(for example, during certain types of RNA export), it is widely accepted that the
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majority of nuclear-cyctoplasmic transport of large molecules fufill the energetic
requirements for transport via RanGTP hydrolysis. A diagram of Ran-GTP
recycling and how it intersects with karyopherin-mediated nuclear transport is
shown in Figure 8b.

III. Nuclear import of mammalian RNA and DNA viruses
All DNA viruses and many RNA viruses that infect mammalian cells must

localize their genomes to the nucleus in order to establish a productive infection

HIV-1, the virus that is the subject of this thesis, is no different in this regard
Therefore, in order to provide a context for the studies on HIV-l nuclear import
described herein, a brief review of known mechanisms of nuclear import for
several other viruses is provided below.

Adenoviruses nuclear import
The Adenovirus family of viruses are non-enveloped DNA viruses with
characteristic isometric capsids of 60-90 nm in diameter and a linear doublestranded DNA genome. These complex and functionally sophisticated viruses
generally encode 11-15 different structural proteins that carryout the various

duties required to establish persistent infection of target cells [reviewed in [99]
Virion proteins include receptor-binding fibers extending from specialized
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penton base complexes at the vertices of the icosahedral cores, and several D N A
binding proteins such as the covalently bound p55 terminal protein at the 5' ends
of the viral DNA [100-103].
After binding to cell surface CAR receptors, these viruses are internalized
by receptor-mediated endocytosis [104]. Following endocytosis, they penetrate
the endosomes by inducing acid-enhanced lysis of the endosomal-limiting
membrane, and are then released into the cytoplasm [105]. The viruses are then
transported through the cytosol to the nucleus where a large fraction bind to the
nuclear pore complexes that adorn the nuclear membrane [106]. During nuclear
transport, adenoviruses particles use microtubules and microtubule-dependent
motors [107].
As the adenovirus particles migrate from the endosomes to the NPC, they
undergo a series of programmed steps that appear to weaken the integrity of the
sturdy viral capsid, allowing it to release its precious cargo of viral genetic
information only once it has localized to the nuclear pore. The molecular

alterations are triggered by receptor interactions, exposure to acidic pH, re-entr
into a reducing milieu, and finally by interactions with the NPC [reviewed in
[108]]. As fibers are stripped from the incoming viral particle once it emerges

from the endosome, capsid stabilizing proteins dissociate from the viral core, and
a protein that connects the DNA to the inside capsid's wall, protein IV, is
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digested by a viral cysteine protease called p23 [109,110]. Once the stripped
adenovirus particle reaches the NPC it encounters factors that trigger the final
stages of particle dissociation. The FG nucleoporin Nup214/CAN is the docking
site for adenoviral particles at the NPC, and unlike some other viruses, nuclear
transport of the Ad2 virion presumably occurs in a karyopherin-independent
manner [111]. By directly targeting a constituent of the NPC, in this case the
filatmentous Nup214/CAN protein present on the cytoplasmic side of the NPC,
the adenovirus particle ensures robust and rapid nuclear localization of its
genome. Adenovirus has taken nuclear import a step further, and it appears that

nuclear localization of the viral genome is a key regulatory step in the viral lif
cycle rather than a mundane requirement. This regulation is manifested in the
binding of histone HI to the Nup214/CAN docked adenovirus particle, which
allows the viral DNA to be shuttle through the nuclear pore via the same
karyopherin-dependent mechanisms that histones use during normal cellular
metabolism [111].
Of the DNA-binding proteins encoded by adenovirus, protein VII is
thought to have a histone-like DNA-condensing function. It enters the nucleus at
the same time as the DNA, and it is possible histone HI and protein VII act in
concert to thread the DNA through the pore as a nucleoprotein complex [111,
112]. The terminal protein p55 covalently associated with the 5' end of each Ad
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D N A strand also enter the nucleus and play an important role in anchoring the
viral DNA to the nuclear matrix [113]. Another Ad DNA binding protein, protein
V, does not seem to enter with the DNA and its function during viral nuclear
import remains unknown [108]. A small amount of the hexon protein from the
incoming virus also finds its way into the nucleus, but this probably occurs
independently of nuclear import of the viral DNA. While a precise role in the
viral life cycle has not been assigned to all of the proteins encoded by
adenovirus, the mechanism of Ad nuclear-cytoplasmic transport is one of the
most clarified for mammalian viruses.

Hepatitis B virus nuclear import
The hepatitis B virus (HBV) is a prototype member of the family
hepadnaviridae. It is enveloped, and has an icosahedral capsid core 32 nm in
diameter. The protein shell is composed of 240 copies of a single protein, called
the core protein, and expression of this protein alone is sufficient for the
formation of a core particle [114]. Hepadnaviruses have a DNA genome, but
because they replicate via an RNA intermediate, they require reverse
transcription [115]. HBV and other hepadnaviruses enter the cell via receptor
mediated endocytosis [116-118] and gain access to the cytosol via membrane
fusion in endosomes [116]. The viral DNA is then transported to the nucleus
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where the R N A template for reverse transcription (the pregenome) is synthesized
by cellular RNA polymerase II [119]. After export to the cytoplasm, this viral
RNA is used as a template for translation of the core protein and polymerase
(polymerase or "P" protein), and it is also packaged into progeny core particles
[120]. The RNA is reverse transcribed by the trapped P protein to the partially
double-stranded DNA, and the polymerase remains covalently linked to the
minus strand [121].
As the viral DNA in the incoming HBV virion is not intrinsically
karyophilic [122], one or more of the structural proteins of the core must be
responsible for mediating nuclear import of the HBV genome. The core protein is
the leading candidate as a facilitator of viral nuclear import. The most
compelling evidence that the core protein is essential to HBV nuclear import

comes from studies with bacterially-expressed core particles that contain the core
protein but no other components of the virus [123]. In an in vitro assay using
digitonin-permeabilized human hepatoma HuH-7cells, these HBV cores bind
specifically to the NPCs [123,124]. NPC binding was inhibited by wheat germ
agglutinin, by anti-nuclear pore complex antibodies, and by peptides
corresponding either to classical nuclear localization signals (NLS) or to COOHterminal sequences of the core protein [123]. Binding was dependent on the
classical soluble nuclear transport receptors karyopherin a and |3. Nuclear
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localization only occurred w h e n the core protein w a s phosphorylated, suggesting
that phosphorylation is required to induce the exposure of a cryptic NLS in the
C-terminus of the HBV core protein that allows the virion to bind karyopherins
and traverse the NPC by co-opting classical cellular nuclear import pathways
[123,124]. Indeed, the C-terminus of the HBV core protein contains five potential
Ser/Thr phosphorylation sites, and this arginine-rich stretch of sequence (amino
acids 145-183 in HBV) has homology to classical basic nuclear localization
signals [123,125,126].
The HBV NLS sequence overlaps with the RNA packaging domain (amino
acids 141-164), as well as with a region that supports plus-strand DNA synthesis
during genome maturation [127,128]. Prior to core maturation, these C-terminal
sequences are present inside the central cavity of the core [126]. However, to
become functional NLSs, they must be somehow exposed at the outer surface of
the core. Perhaps core protein phosphorylation induces a conformational change
that exposes these peptides on the outer surface of the virion where they can
serve as substrates for karyopherin-mediated nuclear import. Cryoelectron
microscopy studies show large holes in the capsid wall between individual core
proteins [114]. These openings could allow the NLS peptides to poke out to the
virion surface, where they can have access to the nuclear transport receptors
(kapcx/ P) in the cytosol, without major changes in overall core architecture.
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Whether or not significant viral core disassembly is necessary for H B V virion

nuclear import (as is seen in the case of adenovirus nuclear import) is uncertain.
However, the recent report from Rabe et al. suggests that HBV capsids were
imported in intact form through the nuclear pore and localized to the interior of
the NPC at the nuclear basket [124]. Import depended on phosphorylation of the
capsid protein and was mediated by the cellular transport receptors karyopherin(X and -3- However, the uncoating reaction was independent of RanGTP binding,
and occurs through a mechanism different than the one normally used to
dissociate karyopherin-imported cargo in the nucleus [124]. Hepadnavirses are

unusual in that a fraction of the cores do not leave the cell in the form of proge
virus but deliver their DNA directly into the nucleus of the host cell in which
they have assembled. This is apparently required to replicate the viral DNA in
the nucleus, which eventually reaches 20-50 copies per cell, and may be
responsible for sustaining a level of latency in infected cells [115].

Influenza nuclear import
Influenza viruses are enveloped animal viruses with a segmented,
negative-sense RNA genome [129]. Individual influenza virions are typically 80
-120 nm in diameter and often appear filamentous, especially when taken from
fresh isolates [129]. They have eight distinct RNA molecules (viral chromosomes)
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individually packaged into viral ribonucleoprotein complexes (vRNPs) that
contain multiple copies of nucleoprotein (NP) and a single copy of a
heterotrimeric polymerase. NP forms a proteinaceous core around which the
RNA is wound in a helix [130]. The unwound length of the individual vRNPs
varies from 20 to 80 nm depending on the size of the RNA [131]. However, the
diameter of the rod-shaped vRNP particles is constant (between 10 and 20 nm)
and they are small enough to overcome the size exclusion limit (~25 nm) of the
nuclear pore and passively diffuse through the NPC. Indeed, current evidence
suggests that incoming influenza vRNPs enter the nucleus in intact form through
the NPCs [132], reminiscent of HBV nuclear import of its mostly intact viral
particle. The NP and the viral polymerase accompany the RNA into the nucleus
where they are required for transcription and replication [131].
Prior to nuclear import of vRNPs, these sub-viral structures must undergo
two distinct low-pH-induced changes. First, an acid-induced conformational
change in HA is required to trigger fusion and escape of the vRNPs into the
cytoplasm [133] . Acidification has also been shown to induce an irreversible
change in Ml, resulting in its dissociation from vRNPs [134,135]. The dissociated
vRNPs are thus delivered to the cytosolic compartment from which they rapidly
and efficiently move into the nucleus via the NPCs. Similar to what is seen
during adenovirus import, dissociation of the influenza sub-viral complexes is a
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key regulatory event in its virus life cycle. It has been s h o w n that the antiviral
drug amantadine, which blocks the M2 ion channel, thereby preventing
endosomal acidification and viral uncoating, also abrogates nuclear import of the
vRNPs [136-138].
While all of the known protein components of the vRNPs carry some type
of NLS (as they must undergo transport to the nucleus after synthesis in infected

cells), responsibility for nuclear transport of the influenza genome appear to fal
on the NP protein [139]. NP is thought to mediate influenza nuclear import via
classical basic-type NLS and interaction with the heterodimeric karyopherina/ (3
molecules [139]. NP can also mediate the import of RNA with which it is
complexed, implying that the NLS does not overlap with the RNA interaction
domain. The import of the NP proteins alone was originally shown to depend on

a basic-type NLS close to its N terminus [140,141], but it is probable that this N
terminal NLS is dispensable for the process of viral genome nuclear import, as it
is not conserved in other orthomyxovirus subtypes [142] .
Unlike adenovirus particles, there is no evidence that influenza vRNP transport
along any cytoskeletal elements once they have been released from endosomes
[143,144].
Figure 9 summarizes the various routes of nuclear entry that are
employed by adenovirus, hepatitis B virus, and HIV, which is the subject of this
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thesis. All infectious viruses that rely on the nucleus as a site for their replication
are presented with the challenge of passing through the nuclear pore complex
(NPC) which tightly regulates molecular traffic into and out of the nucleus.

Consistent with their roles as obligate intracellular parasites, many viruses have
adapted to use the same machinery that the host cell utilizes for macromolecular
transport through the NPC. Thus, the capsid proteins of several viruses,
including those adenoviruses and hepadnaviruses like HBV, have evolved to
contain NLS sequences that allow them to interact with soluble nuclear transport
receptors like the karyopherins in order to deliver their genetic information to
the nucleus. Notably, many such viruses undergo significant molecular
alterations (i.e. decapsidation, stripping, acidic-induced structural changes)
before they are capable of performing nuclear import. Lentiviruses like the
human immunodeficiency virus (HIV) are no different in this regard, as a
significant amount of rearrangement of the viral core constituents occurs as
virions enter the target cell cytoplasm ande pre-integration complexes (PICs) are
assembled. This thesis describes the potential role of one of the viral proteins
that is present throughout the transmogrification of the incoming HIV viral

particle, namely the HIV integrase, in facilitating the active nuclear transport o
the reverse transcribed viral genome into the nucleus.
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Figure 9. Mechanisms of D N A and R N A virus nuclear translocation. The proposed
mechanisms for nuclear import for HIV-1, Adenovirus type-2 (Ad2), and Hepatitis B
virus (HBV) are shown. A ) HIV-1 nuclear import follows viral fusion/ entry and reverse
transcription and precedes the step of proviral D N A integration in the nucleus. It is
unclear whether HIV-1 utilizes classical nuclear import receptors such as karyopherinalpha and karyopherin-beta, and the precise mechanism of HIV-1 nuclear import is
unknown. B) A d 2 nuclear import follows viral endocytosis/endosomal escape and
relies upon a combination of host cell factors (karyopherin-alpha, karyopherin-beta,
histone HI, and heat shock protein 70, all bound to the N P C via Nup214/CAN) to
facilitate the breakdown of its capsid at the N P C , allowing the viral D N A to be injected
through the nuclear pore and into the nucleus. C) H B V nuclear import occurs after the
virus enters the cell by endocytosis and escapes the endocytic vesicle via a pHindependent mechanism resulting in their release into the cytosol. Once in the cytosol,
H B V virions bind karyopherin-alpha/karyopherin-beta heterodimers, traffic to the
nucleus, and disassemble at the N P C to release the covalently closed circular viral D N A
into the nucleus where it is transcribed into viral R N A , exported, and then reverse
transcribed to H B V viral D N A in the cytosol.
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This w o r k also describes the identification of certain endogenous host cell
factors (Lvl/TRIM5-CX) that can bind to incoming HIV and SIV virions,
preventing them from completing reverse transcription and presumably

abrogating their ability to localize to the nucleus in non-permissive primate cell
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chaptfr g. post-Entry restrictions to HIV-1 replication
/. Species-specific restriction of lentiviral infections

Many lentiviruses that infect humans and non-human primates exhibit a
highly restricted species tropism. HIV-1, for example, is unable to replicate in
cells derived from several nonhuman primates, including rhesus macaques, the
most prominent monkey species used in animal models of AIDS [145] .
Therefore, it would be of great scientific interest to those seeking to develop
better animals models to study HIV-1 to determine the precise step of the viral

life cycle at which replication is blocked in such non-permissive primate cells. I
had previously been demonstrated that the block to HIV-1 replication in

macaques occurs primarily during the early steps of the viral life cycle, such tha
reverse transcription does not proceed to completion [146,147]. However, the
exact point in the viral life cycle where this species-specific restriction was
manifest remained unknown. Indeed, the virus could have been inhibited at any
of the steps that precede reverse transcription, such as envelope/receptor
binding, viral membrane fusion/entry, or during the process of viral capsid
uncoating.
Observation of the SHIV rhesus macaque animal model, where a simian
immunodeficiency viruses from macaques (SIVmac) is engineered to contain
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envelope genes from HIV-1, reveals that such hybrid viruses can replicate in
these animals [148]. Therefore, inefficient HIV-1 replication in this nonpermissive species cannot be explained entirely by envelope-receptor

incongruities [149-151]. While some portion of the post-entry restriction of HIV-1
in primates may be due to surface receptor-envelope incompatibility [152],

certain primate cells display dramatic differences in their ability to support the
early steps of the HIV-1 and SIV life cycles (even when pseudotyped with viral

envelopes that have broad cellular tropism, such as the vesticular stomatitis viru
glycoprotein (VSVg)) that cannot be fully explained by the differences in
receptor-envelope binding [149,153]. Indeed, the existence of cellular factor(s)

within the intracellular milieu that restricts HIV and SIV infection at a post-ent
pre-integration step in non-permissive cells may provide a plausible explanation
to reconcile these observations.
In mice, an example of such a host cell retrovirus-inhibiting factor is found

in the case of the Friend virus susceptibility factor 1 (Fvl), a mouse gene product
that can specifically block certain strains of the murine leukemia virus (MLV)
[154,155]. The Fvl protein is derived from an ancient endogenous mouse
retroviral gag gene, and disables incoming virions by binding to the MLV capsid
(CA) immediately following entry into the cytoplasm, thereby preventing the

virus from progressing through the remainder of the early steps in its replicative
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cycle. This phenomenon, often referred to as the "Fvl phenotype" is saturable,
and the addition of high levels of incoming virions (infection at very high MOI)
can overcome the resistance to infection in non-permissive cells [156,157].
Interestingly, this Fvl phenotype is also observed in certain human cells lines
that are non-permissive for MLV infection and is caused by a genetically
unrelated factor called Refl [158,159].
In the Fvl phenotype of MLV, a single-amino-acid residue in the CA

protein of the incoming virion determines the N- or B-cell tropism of the virus. B
tropic MLV efficiently infects BALB/c cells but has only limited ability to
replicate in NIH-3T3 cells, showing about a 100-fold lower titer. The opposite is

true for N-tropic virus. The particular Fvl locus in the host determines whether a
cell will be of the B- or N-type. The protein product of Fvl gene is presumed to

interact with CA in the infecting virus, in a manner that is affected by this sing
amino acid change in the virion. While the Fvl gene has recently been cloned
[158], its precise mechanism of action remains to be elucidated. However, it is
known that the MLV CA protein is a component of the viral preintegration
complex (PIC) in newly infected cells [160], reinforcing the proposed mechanism
of how the mutations in MLV CA can block downstream events in the viral life
cycle such as the completion of reverse transcription and nuclear import. The
importance of the retroviral CA protein to determining the viral tropism is
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underscored by the observation of cyclophilin A binding to the C A of HIV-1
[161]. Treatment of virus-producing cells with cyclosporine, a drug that blocks
cyclophilin A binding to CA and prevents its incorporation into budding virions,

results in non-infectious virus that is blocked at an early step of the viral life
[162,163]. Cyclophilin A binds to a loop in CA containing proline 90 in an
unusual trans-conformation [162]. How this binding affects virion infectivity is
unknown, but there may be a causal relationship between cyclophilin A binding

to CA and the activity of a soluble factor that blocks lentivirus infection. Other
suggest that the biological function of cyclophilin A binding to CA might be to

destabilize the shell of CA proteins, thereby facilitating core disassembly during
uncoating and allowing the infecting virion to proceed smoothly through the
remainder of its replication cycle [164].
Might there be a host cell factor that demonstrates a similar virusrestricting phenotype in target cells for simian and human immunodeficiency
viruses? Our recent studies have indicated that there does exist in certain
primate cells a saturable inhibitor of primate lentiviruses, which we have termed

Lvl (Lentivirus susceptibility factor 1), that blocks HIV and SIV replication at a

early step of the virus life cycle in non-permissive cells [149]. Recently, screeni
of a rhesus monkey cDNA library has identified tripartite interaction motif 5
-alpha (TRIM5-CX) as a factor that confers resistance to HIV-1 infection [165].
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Subsequent experiments have revealed that Lvl, Ref 1, and TRIM5-0C are most
likely the same molecule, as expression of TRIM5-CX confers resistance to
lentivirus infection to otherwise permissive cell types [166]. The work presented

in this thesis provided the first proof that Lvl/ TRIM5-CX restriction occurs soon
after the virus enters the infected cell, during the earliest steps of reverse
transcription.

II. Lv-l/TRIM5-a restriction occurs at the step of early reverse transcription
A schematic diagram of the real time PCR assays that were developed to
measure the various viral DNA intermediates (early and late reverse transcripts
and 2-LTR circles) is shown in Figure 10. A more detailed description of these
assays, including the locations of PCR primers and molecular beacons can be
found in Chapter 6 Materials and Methods. In order to reduce the possibility of
that contaminant DNA from the media used to make the viral stocks (i.e. leftover
DNA from HEK 293T cell transfections) might confound our measurements of
the viral DNA intermediates (specifically reverse transcription products) from
infected cells, we developed a sensitive real time PCR assay to monitor the
presence of this DNA species in our samples [Figure 10].
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Figure 10. Description of Real Time P C R assays. Schematic diagrams depict the real
time P C R assays used to measure various viral D N A intermediates during HTV
infection. A) The Early RT primer set amplifies a small stretch of viral D N A preceding
the primer binding site (PBS) and measures "strong stop" reverse transcripts that occur
before the first template strand switch. The Late RT assay uses a reverse primer that
anneals downstream of the PBS, giving an estimate of the full length reverse transcribed
viral D N A . The 2-LTR circle assays utilizes a primer set and beacon that spans the LTR
"junction" following the end-joining ligation reaction that occurs once the viral D N A is
in the nucleus. A "contamination" control P C R assay with one primer specific for the
plasmid D N A "backbone" of R73 and other specific for a region in the 5'LTR allows the
accurate quantification of the amount of viral D N A carried over from the transfection
used to make the viral stocks. B) A n example of a standard curve generated using a 2LTR circle plasmid as the template in this assay, starting with one million copies per
nanogram of input D N A and 10-fold serially diluted to 10 copies per nanogram.
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Using this assay, w e were able to detect small amounts of contaminant D N A
from the viral stocks, but the level of this DNA was on average 2-3 orders of
magnitude below the level of reverse transcripts measured, and could be further
reduced by addition of increasing concentrations of Dnase I enzyme to the virus
stocks prior to infection, as well as by increased washing of the cells after
infection.
In order to determine the step of the viral life cycle at which the Lvl
phenoytpe is first manifest, we used the above real time PCR assays to monitor

the early events in the viral life cycle in various primate cells. We first inocul
several primate cell lines with increasing amounts of VSV-G-pseudotyped HIV-1

and STVmac reporter viruses. Large differences exist in the susceptibility of some

of the cell lines to HIV-1 versus SlVmac infection at low multiplicity of infecti
(MOI= 1). Specifically, whereas the human cell line HeLa was approximately
equivalently infected by HIV/GFP and SIV/GFP, Rhesus monkey (Rh.F) and
Owl monkey (OMK) cells were infected at an almost 100-fold greater frequency
by SIV/GFP than by HIV/GFP. In contrast, the squirrel monkey cell line, Pindak,
exhibited precisely the opposite phenotype. The African green monkey (CV-1)
cell line was almost equivalently infected by each of the viruses, although both
appeared less infectious on CV-1 cells at low MOI as compared with HeLa cells.
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Accordingly, w e then infected HeLa, O M K , and Rh.F cells with various
doses of HIV GFP beginning with an MOI of 1000 with four 10-fold serial
dilutions dilution until an MOI of 0.1 and then measured the accumulation of
viral DNA intermediates at each dose. Analogous to the result seen with GFP
expression measured by fluorescence activated cell sorting (FACS) analysis,
OMK and Rh.F cells produced dramatically less reverse transcribed DNA
following HIV GFP infection when compared to permissive HeLa cells [Figure
11a]. The dramatic species-specific restriction conferred by Lvl / TRIM5-(X is

even more clearly evident when one looks at the step of late reverse transcription
[Figure lib] or at the viral 2-LTR circles which form following nuclear import
(not shown). Indeed, 2-LTR circles were only detected in the permissive HeLa
cells (72 hours post-infection), and no circles were evident from the nonpermissive Rh.F and OMK cell infections. This reinforces the assertion that Lvl/

TRIM5-a restriction truly occurs at a step that is prior to nuclear entry, and may
point to a temporal association between reverse transcription and nuclear
import. For example, Lvl/TRIM5-a binding to capsids would not only prevent
the conformational changes necessary to form active reverse transcription
complexes (and thus block reverse transcription), but would also prevent the
formation of pre-integration complexes competent for nuclear import. While the
absence of 2-LTR circle intermediates in the non-permissive HIV infected cells
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suggests a defect in nuclear import accompanies the block to reverse
transcription, future studies that seek to directly visualize Lvl/TRIM5-cx bound
HIV cores will be needed to confirm this assumption.
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Figure 11a. Titration of VSV-HIV G F P on non-permissive cells reveals Lvl/TRIM5alpha restriction is blocked at the step of early and late RT. Reduced accumulation of
HIV-1 c D N A in nonpermissive primate cells is evident at low MOI. A ) HeLa, Rh.F, and
O M K cells were inoculated with varying amounts of VSV-G-pseudotyped HIVGFP and
total D N A was isolated and reverse transcripts measured by real-time P C R 48 h later.
Alternatively, (B) cells were inoculated with 25 ng (MOI ~0.1) of HIV-GFP, and reverse
transcripts w e r e m e a s u r e d at the indicated t i m e s after infection [62].
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Figure lib. Late reverse transcription is impaired in non-permissive primate cells.
HeLa, O M K , and Rh.F cells were inoculated with 25 ng of HIV-GFP as above and total
D N A was isolated 48 hours after infection and subjected to real time P C R analysis of
completed late reverse transcripts. The inhibitory effect of Lvl/TRIM5-alpha produces a
dramatic reduction in late reverse transcription in non-permissive O M K and Rh.F cells,
which coincides with a lack of viral gene expression (GFP) as measured by FACS
analysis, and a reduction in 2LTR circle copies. Data are representative of three
independent experiments.
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Chapter a. Nuclear Translocation of HIV-1

Defining the role of HIV-1 integrase during viral nuclear import
Integrase has been mutagenized extensively in the context of numerous
functional studies, but a systematic set of mutants has not yet been employed to

localize determinants regulating its nuclear import. In previous studies [167] the
integrase coding region was fused to the carboxyl-terminus of enhanced green
fluorescent protein (EGFP), and the construct was transfected into HEK 293T
cells. As expected, the 60 kD chimeric protein (EGFP-IN) localized
predominantly to the nucleus in regions distinct from the nucleolus. An extensive
set of charged-cluster-to-alanine mutations and carboxyl-terminal deletions were
then introduced into the integrase portion of the EGFP-IN construct, and their
effects on its sub-cellular localization determined. Alanine substitutions within
the carboxyl-terminus of IN spanning residues 236-40 and 262-266, resulted in
complete exclusion of EGFP-IN from the nucleus [167].
Mutagenesis of native integrase or transfer of the integrase carboxylterminal domain to otherwise cytoplasmic proteins [shown in Figure 12]
confirms the existence of a potent NLS in this region. Remarkably, the charged
residues do not by themselves confer NLS activity, as appending small 10-20 mer
peptides corresponding to these regions within IN were not able to redirect
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excluded e G F P - M B P fusion proteins to the nucleus [167]. Therefore it appears

that the NLS activity of IN requires the structural integrity of a three dimension
SH3-like fold previously determined by others to exist in the carboxyl-terminal
domain of integrase [168]. In addition, it is important to note that alignment of
the amino acid sequences from over five hundred different primary isolates of
HIV, spanning several of the known viral quasispecies including clades A, B, C,

D, E, and G shows that this region of integrase is highly conserved, especially at

the amino acid residues that we have identified as being critical for NLS activity
[Figure 13]. This may underscore the importance of this region to the viral life
cycle, specifically the residues critical to NLS function, as all viral subtypes
would need to conserve this IN NLS region in order to interact with common
cellular nuclear import machinery allowing the PIC to make it to the nucleus to
become stably integrated into host chromosomal DNA. Indeed, the

evoluntionary importance of this structure to the virus could be significant, as t
residues that define the NLS element are highly conserved in multiple primate
and non-primate lentiviridae. The conservation is complete in placement and
sequence at the specified positions within the integrase protein including
residues K236, R262, R263, K266, and partially at position K240.
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Figure 12. The C-terminal domain of HIV-1 integrase encodes an N L S activity that
localizes large, otherwise cytoplasmic proteins to the nucleus. H E K 293T cells were
transfected with D N A constructs encoding a fusion protein of enhanced green
fluorescent protein (eGFP) and maltose binding protein (MBP) of 75 kiloDaltons, in
excess of the nuclear pore exclusion limit (50-60 kD). The addition of the last 76 amino
acids of HIV-1 integrase (the entire C-terminal domain) to this eGFP-MBP fusion
resulted in the nuclear localization of this otherwise cytoplasmic protein. Inclusion of a
double (K236/240A) or triple (R262/3/6) mutation in the appended IN C-terminus
resulted in nuclear exclusion. A ) control eGFP-MBP alone, (B) eGFP-MBP-IN-WT, (C)
eGFP-MBP-IN-K236/240A, (D) eGFP-MBP-IN-R262/3/6A. All cells are shown at 63X
magnification and each panel is representative of 50-100 eGFP-positive cells per field,
four fields per slide, and representative of three separate experiments.
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For the non-primate lentiviridae EIAV, FIV, BIV and Visna virus, this
overall pattern of basic residue conservation within the integrase C-terminus is
noticeable as well. Generally, clusters of basic residues are roughly 25-30 amino
acids apart with hydrophobic residues involved in maintaining both the SH3
monomeric structure and the SH3:SH3 dimer interface notably preserved.
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Figure 13. Conservation of A m i n o Acid Sequence in the C-terminal domain of HIV-1
Integrase. Five hundred and twenty H I V isolates across clades A, B, C, D, E and G were
aligned in the pol gene region corresponding to the last 50 amino acids of the integrase
protein. Overall, with the exception of 3 residues that displayed great variation
(indicated b y an *), there is a high degree of sequence conservation in this region,
especially at the residues that w e have identified as relevant to viral nuclear import (red
arrows).
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I. The carboxyl terminus of HIV-1 integrase specifies a transferable nuclear localization
signal (IN NLS) that functions in primary cells
As mentioned previously, introducing mutations in the integrase region of
pol can often have pleiotropic effects on essential viral activities other than
nuclear import, such as PIC assembly or reverse transcription. As the integrase
SH3 domain has been shown to bind DNA non-specifically in vitro [169-172], and
one of the set of mutations that we have identified as critical for NLS activity
overlaps a residue (Lys at position 264) that is important for this non-specific
DNA binding, we sought to perform experiments to preclude the possibility that
the NLS we have identified simply coordinates host chromosomal DNA binding.
If this were the case, then the IN C-terminus could mimic the activity of a bona

fide nuclear localization signal in actively dividing cell lines (such as HEK 293T
cells) by providing, for example, a nuclear retention function allowing the eGFPIN fusion proteins to latch onto euchromatin nonspecifically as the cell divides.
Figure 14 shows that the integrase NLS element is capable of providing nuclear
import activity to otherwise cytoplasmic eGFP-MBP fusion proteins even in nondividing cells of primary origin (immature dendritic cells and CD4+ T cells);
evidence that the integrase NLS is operational for import when the nuclear
membrane remains intact and when no transient access to chromosomal DNA
during cell division is available. The process of nucleofection that was used to
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introduce the eGFP-MBP-IN plasmid D N A s into non-dividing D C and T cells
produces transient porosity of the cell's plasma membrane but the nuclear
membrane remains intact [173], and, while considerable cell death is evident in
the samples following this procedure, there is no evidence of cell division as
measured by CSFE staining and FACS anaylsis of samples after nucleofection
(not shown). Therefore, its is unlikely that the apparent karyophilic activity
provided by the HIV IN C-terminus is simply an artifact of experiments
performed in dividing cells, which highlights the potential importance of this
domain of integrase as a facilitator of viral nuclear import during natural
infection in vivo.

II. Kinetics of H I V IN N L S mutant viruses in dividing and non-dividing cells

Reconstruction of these integrase NLS mutants into an otherwise
infectious HIV-1 proviral clone (R7-3 with a macrophage tropic (Yu2) or T cell

tropic (HXB-2) envelope) resulted in a replication-defective phenotype in all cell

types tested. Figure 15 shows the results of infection or the T lymphoblastoid cel
line CEM-SS cells, primary human monocyte-derived macrophages (MDM), and
primary CD8-depleted PHA-activated peripheral blood lymphocytes (PBLs) with
either macrophage tropic or T cell tropic HIV variants containing mutations to
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Figure 14. (Caption continued on page 67).
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Figure 14. The C-terminal domain of HIV-1 integrase displays N L S activity in nondividing dendritic cells and C D 4 + T cells. Primary human dendritic cells and C D 4 + T
cells were transfected with plasmid D N A encoding various eGFP-MBP-Integrase Cterminal fusion proteins using the A M A X A Nucleofection procedure as per the
manufacturer's protocol. At 12 hours post-nucleofection, cells were washed, fixed with
4 % PFA and mounted onto microscope slides with medium containing D A P I to stain the
nuclear D N A (blue). Cells that were positive for eGFP expression (green), and therefore
expressing the eGFP-MBP-Integrase fusion constructs, were visualized by confocal
microscopy using a DeltaVision microscope. Constructs specifying eGFP conjugated to
either the SV40 virus N L S or nucleoplasmin N L S were included as controls for nuclear
import. A construct encoding the eGFP-MBP fusion protein alone (75 kD, too larger to
passively diffuse through the N P C ) was used as a control for nuclear exclusion. A )
Addition of the C-terminal 76 amino acid polypeptide (residues 212-288) of HIV-1
integrase confers an N L S activity to an otherwise cytoplasmic protein in primary human
C D 4 + T cells. B) The C-terminal HTV-1 Integrase N L S is also functional in non-dividing
primary human dendritic cells. Mutation of the residues previously shown to affect HTV
-1 nuclear import (K236/240A and R262/3/6A) in the context of this appended Cterminal domain resulted in nuclear exclusion of the fusion protein. All cells are shown
at 100X magnification and each panel is representative of 50-100 G F P positive cells per
field, four fields per slide, and a minimum of three separate experiments.

67

the defined N L S regions K236/240A and R262/3/6A. Examining the

infected cell supernatants for the presence of the viral p24 Gag antigen indicates
that these mutations result in a non-productive infection when compared to

cognate wild type viruses. Similarly, transfer of infected cell supernatants taken
from each cell type after seven days in culture produced the same pattern of

infection when added to fresh cultures of target cells that are permissive for HIV
infection such as PHA-stimulated CD8-depleted PBLs. Thus, incorporation of
this double (K236/240A) and triple (R262/3/6A) mutation into an otherwise

infectious proviral molecular clone results in a virus that is replication-defecti
presumably because viral nuclear import is unable to proceed to completion.

III. Real time PCR analysis of viral DNA intermediates after infection with IN NLS
mutant viruses
In order to examine the effects of NLS mutants on specific early stages of
the HIV life cycle, we developed a series of sensitive, stage-specific real-time
PCR-based assays that quantitatively measure progression through reverse
transcription and nuclear import. In agreement with other kinetic PCR assays

[174], calibration of a typical spreading infection with wild-type virus exhibits a

2- to 4- log increase over baseline for each of the viral DNA intermediates over 4
hours, as the stage-specific products appear sequentially.
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Figure 15. Replication kinetics of HIV IN NLS mutant viruses in dividing and nondividing cells. Non-dividing primary human monocyte-derived macrophages ( M D M )
and CD8-depleted peripheral lymphocytes (PBL) were infected with HTV molecular
clones derived from the H X B 2 strain (R7-3), containing our N L S mutations in the
integrase region of the pol gene, and pseudotyped with either a T cell-tropic or M-tropic
(Yu2) HTV envelope. After 6 hour initial incubation with virus, cells were washed and
media was collected at the indicated time points A ) M D M infected with wild type
(WT) virus produced p24 consistent with a productive spreading infection while N L S
mutant viruses did not (K236/240A=M1, R262/3/6A=M2, 260stop=M3). B) The N L S
mutant viruses are replication defective in the CEM-SS lymphoblastoid cell line. C)
CD8-depleted PBL do not support replication of the N L S mutant viruses, while W T
virus readily replicates in these cells (media assayed at a single time point 8 days post
infection in panel C). Data are representative of five separate experiments.
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Notably, the copy number per cell equivalent of each stage-specific
product is approximately 1-2 orders of magnitude less than the previous step,
with early reverse transcripts the most abundant and 2-LTR circles the least,

highlighting the relative inefficiency of the conversion of viral RNA into nuclear
viral DNA species.
Single-cycle infections with wild type and NLS-mutant R5 and X4 viruses
were performed in CD8-depleted, activated primary lymphocytes and MDM,

respectively. In all cases, the integrase strand-transfer inhibitor, L-731,988 [175
was added to the infections. This inhibitor has no effect on the nuclear
localization of the enzyme or viral DNA accumulation in the nucleus but renders

it catalytically inactive at the strand-transfer step [175]. Inclusion of the stran
transfer inhibitor allowed a comparison of all viruses during a single round of
infection. In addition, it increased the utility and accuracy of the 2-LTR circle
assay as a marker for PIC nuclear import by eliminating potential variations in
integration efficiency between the wild type and mutant viruses. This is
important for avoiding confounding effects, since the frequency of viral
integration is inversely correlated with the accumulation of the circular viral
DNA species found in the nucleus [42,175].
Figure 16 shows that while wild type and integrase NLS-mutant viruses

are able to complete the late stage of reverse transcription with equal efficiency
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all NLS-mutant viruses exhibit a severe defect in proviral nuclear import, as
measured by 2-LTR circle formation in primary human MDM. The same pattern
was observed in CD8-depleted PBL [Figure 17].
In order to ensure that the presence of a pharmacological integrase
inhibitor did not confound our results by exerting possible pleiotropic effects,
experiments were repeated in the absence of the drug. Here, MDM were infected
with wild-type and NLS-mutant viruses containing an additional mutation, IN
D116A, which by itself has no effect on nuclear localization of the integrase
protein, reverse transcription, or transport of the viral genome into the nuclear
compartment, but prevents integration and further progression through the viral

life cycle [42]. Results using these viruses were the same as those obtained using
the small molecule integrase inhibitor, with a specific and severe two-log defect

evident at the level of 2-LTR circle formation. Thus, the functional integrase NLS
described here is necessary and sufficient for efficient nuclear accumulation of
the viral genome in cell types reflective of the natural target cells for HIV
infection in vivo.
To rule out any effects the amount of virus used to initiate an infection
might have on the interpretation of our results, we determined the level of late
reverse transcripts over a two-log range of X4 and R5 viral input concentrations
(1-243 ng p24).
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Figure 16. Real time P C R analysis of viral D N A intermediates in primary h u m a n
macrophages following infection with H I V I N N L S viruses. Primary h u m a n
macrophages were infected with macrophage-tropic H I V viruses containing the
previously identified integrase N L S mutations K236/240A, R262/3/6A, and 260stop in
the presence of the diketo integrase inhibitor L-731,988. After addition of viral stock,
cells were washed with phosphate buffered saline, then fresh media w a s added and the
infected macrophages were kept in culture with drug for total of 8 days. Total genomic
D N A w a s isolated at 0, 6, 24, 48, 96, and 196 hours post infection and viral D N A
intermediates for late reverse transcription (A) and 2-LTR circles (B) were quantified via
real time P C R . With the exception of the 260stop truncation mutant, the IN N L S
mutations displayed little or no defect in reverse transcription, while there w a s a marked
decrease in 2-LTR circles compared to wild type virus (solid black circles), suggesting
that these viruses are defective for nuclear import. Results are representative of at least 3
separate experiments.
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Figure 17. Real time P C R analysis of viral D N A intermediates in primary h u m a n
CD8-depleted PBL following infection with H I V IN N L S viruses. CD8-depleted,
PHA-activated primary human peripheral blood lymphocytes (PBL) were infected with
T cell-tropic HIV viruses containing the previously identified integrase N L S mutations
K236/240A, R262/3/6A, and 260stop in the presence of the diketo integrase inhibitor L
-731,988. After addition of viral stock, cells were washed with phosphate buffered
saline, then fresh media was added and the infected PBLs were kept in culture with drug
for total of 8 days. Total g e n o m i c D N A w a s isolated at 0, 6, 24, 48, 96, a n d 196 hours post
infection a n d viral D N A intermediates for late reverse transcription (A) a n d 2-LTR
circles (B) w e r e quantified via real time P C R . W i t h the exception of the 260stop
truncation mutant, the I N N L S mutations displayed little or n o defect in reverse
transcription, while there w a s a m a r k e d decrease in 2-LTR circles c o m p a r e d to wild type
virus (solid black circles), suggesting that these viruses are defective for nuclear import.
Results are representative of three separate experiments.
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For example, viral c D N A is unstable in infected cells, with incompletely
synthesized genomes preferentially targeted for degradation [176]. Thus, total

cellular DNA was isolated six hours after infection and the amount of late reverse
transcripts produced was determined for cultures of CD8-depleted PBLs and
MDM. The accumulation of late reverse transcription products in the integrase
NLS mutant is identical to that of the wild-type virus over the range of doses
tested (data not shown), suggesting that any potential dose-dependent effects of
viral innoculum on our reverse transcription measurements are minimal, and
would not confound the measurements of 2-LTR circle products that formed
downstream of the completion of reverse transcription.
Finally, to ensure that the role of integrase in viral nuclear import was
independent of upstream events of the viral life cycle, we attempted to
pharmacologically isolate and continuously monitor a single population of
reverse transcripts for nuclear import. MDM were infected with either wild type
or IN NLS mutant virus in the presence of the integrase strand transfer inhibitor
L-731,988 as described above. Then, at 3 hours post-infection, the non-nucleoside
reverse transcriptase inhibitor, UC-781 [177], was added to block further DNA
synthesis, and the levels of reverse transcript and 2-LTR circle formation was
monitored at various times post-addition by real-time PCR. Under these
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conditions, both the production and stability of viral c D N A transcripts were
identical in the wild type and mutant viral infections [Figure 18a]. However, 2LTR circle formation (presumably from the nuclear import-competent PIC that
formed prior to the addition of the RT inhibitor) was dramatically reduced for
the IN K236A/240A virus relative to the wild-type, indicating a specific and
severe defect for nuclear import when this stage of the viral life cycle is
pharmacologically uncoupled from upstream and downstream events by
treatment with the RT inhibitor UC-781 [Figure 18b].

IV Preintegration complexes and purified proteins from IN NLS mutants are
catalytically active in vitro

In order to prove that our integrase NLS mutants were competent to
perform the normal obligate catalyses of the enzyme, purified versions of both
wild type and NLS mutant codon-optimized integrase proteins (IN MOD) were
made (courtesy of the lab of Dr. Daria Hazuda, Merck). These purified IN
proteins were analyzed using the Quick IN assay for strand transfer described
previously by Hazuda et al. [175, 178-181]. The K236/240A mutant was nearly
equivalent to wild type protein in its ability to perform the strand transfer
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reaction, while both the R262/3/6A and 260stop mutant were impaired (45-50%
of wild type activity) in this assay [Figure 19b (top panel)].
In addition, we developed a quantitative real time PCR based assay for
quantifying integration of the viral genome into a small (186 base pair) target
DNA. Cytosolic extracts containing active pre-integration complexes were made
from macrophages infected with the wild type and NLS mutants, incubated with
a defined amount of the small target DNA, phenohchloroform extracted and
used as a template in our quantitative real time PCR assay for integration.
Figure 19 describes the assay setup and shows the results of both sets of
experiments with purified IN NLS mutant proteins or purified HIV PICs from
the mutant NLS viruses. The K236/240A NLS mutant PICs showed no defect in
their ability to integrate into target DNA compared to wild type PICs. However,
a defect in integration activity was noticed for the R262/3/6A and 260 stop NLS
mutants (50 and 75 percent, respectively) compared to wild type PICs. PIC from
the D116A mutant, as well as PICs from cells infected with wild type virus and
treated with 10 |JM of the strand-transfer inhibitor L-731,988 were included as
controls and produced background levels of integration as expected. Thus, the
results of these experiments suggest that all of the NLS mutants are competent to
some degree to catalyze the strand transfer reaction.
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Figure 18. Pharmacological isolation of viral D N A intermediates at the step of reverse
transcription reveals RT-independent effect of IN N L S mutants on nuclear import in
primary h u m a n macrophages. Primary human macrophages were infected with M tropic HTV containing the IN N L S mutations as well as the D116A active site mutation at
a high M O I (10), then treated with a non-nucleoside reverse transcriptase inhibitor (UC
-781) at 3 hours post-infection. Total genomic D N A was isolated at 0, 6,12, 24, 48, 96,
and 196 hours post-UC-781 addition and viral D N A intermediates for early and late
reverse transcription and 2-LTR circles were measured by real time PCR. Under
conditions where reverse transcription is inhibited, a marked decrease in 2-LTR circles is
apparent for the N L S mutants compared to wild type virus, suggesting that these
mutants are specifically impaired for the step of viral nuclear import. Data is
representative of two separate experiments.
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In the case of the mutants that were compromised for this catalytic activity
(the R262/3/6A and 260stop mutants), this may be due to a decrease in their

ability to bind the target DNA substrate, as residues within this region of IN hav
been implicated in DNA binding [169, 170]. As the K236/240A mutant was
nearly equivalent to wild type integrase activity in both assays, its effects on
nuclear import are independent of its ability to perform the enzymes' normal
catalytic functions in vitro.
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Figure 19. Pre-integration complexes from IN N L S mutant viruses are catalytically
active in vitro. In order to test the ability of the N L S mutant PICs to perform other
obligate catalytic functions of integrase, w e added cytosolic extracts from cells infected
with wild type or N L S mutant viruses to a small 186 base pair target D N A . A) A
schematic diagram of the PIC integration real time P C R assay set up is shown. A
forward primer annealing to a defined stretch of sequence in the target D N A was paired
with a reverse primer and molecular beacon specific for the 5' LTR allowing for
quantitative measurement of an approximately 156 bp integration product. A n example
of a standard curve generated with a plasmid containing this integration product is
shown. B) The Quick IN integration assay of purified IN proteins was performed and
data is expressed as percentage of wild type activity per microgram of protein. PICs
from W T and N L S mutant viruses were incubated with target D N A for 2 hours at 37
degrees C, then integration products were phenol:chloroform extracted and quantified
using the real time P C R assay described above. Both the R262/3/6A and 260stop
mutants displayed decreased integration (50% and 3 0 % of W T respectively), while the
K236/240A mutant showed no integration defect. A D116A active site mutant, and wild
type PICs treated with the integrase inhibitor L-731,988 were included as controls.
Equivalent amounts of PICs (as measured by late RT products in the PIC preps) were
added to 250 ng of target D N A in each reaction. The quick IN assay represents two
independent experiments and the PIC integration experiment was repeated three times.
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V. Digitonin-permeabilized macrophage nuclear import assay system reveals excluded
phenotypes for IN NLS mutants

The cloning and preparation of recombinant factors required for signal-

dependent nuclear transport has accelerated the study of intracellular trafficking
We have maintained collaboration with the laboratory of Dr. Gunter Blobel at

Rockefeller University to facilitate our analysis of HIV-1 nuclear import and this
interaction has been valuable given the remarkable and extensive set of
conventional recombinant nuclear transport factors cloned and purified by this
laboratory. To make use of this knowledge and the latest approaches to the study
of intracellular trafficking, we have developed a semi-intact cellular based
system centered on the selective soponification of the plasma membrane over
that of the nuclear membrane. This system maintains the nucleus (and the
nuclear membrane) structurally intact and in a state competent for signaldependent nuclear pore translocation. Digitonin permeabilization, followed by
extensive washing with isotonic transport buffer, literally "flushes" the soluble
factors required for nuclear import out of the cell's cytoplasmic compartment.

Specific factors required for nuclear transport of a given protein cargo or comple
can be studied in detail by the addition of these factors back into the cell from
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fractionated cytosol preparations or, depending on their availability, from a

specific combination of the recombinant factors and transport factors of interest.
In this reconstituted import system, proteins with active nuclear localization
signals can be found in the nucleus within as early as thirty minutes after
addition to permeabilized cells and reach more than a thirty-fold increase in
concentration into this compartment [182].
In our experiments we used primary human macrophages as the target

cells for permeabilization, as this cell type is relevant to HIV infection in vivo
digitonin-permeabilized macrophage cell system reproduces authentic nuclear

protein import in that it requires a functional nuclear localization sequence, ATP
and cytosol, is temperature dependent, and is inhibited by wheat germ
agglutinin (WGA), a molecule that binds the nuclear pore and is a potent
inhibitor of nuclear transport in vivo. The results obtained using purified IN
proteins [Figure 20] containing our NLS mutations, as well as PICs from cells
infected with the NLS mutant viruses [Figure 21], have reinforced our belief that
the carboxyl-terminal domain of integrase is indispensable for viral nuclear
import, as the nuclear excluded phenotype we observed in the previously
described studies of eGFP-MBP fusion proteins containing the NLS mutations
can be recapitulated in this ex vivo system. Digitionin-permeabilized
macrophages were incubated with nuclear transport mixtures containing
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purified proteins or PICs (cytosolic extracts from infected macrophages) for 2
hours to allow nuclear import to occur, then cells were washed, fixed with
paraformaldehyde (PFA), and immunohistochemically stained with monoclonal
antibodies specific for the N-terminus of HIV integrase. Purified GST-GFP fusion
proteins plus or minus the NLS peptide from nucleoplasmin (courtesy of Dr.
Elias Coutavas, Rockefeller University) were subjected to the same conditions

and visualized in cells in order to clearly define what a nuclear localized protei
looks like inside of permeabilized macrophages. Other controls included
immunostaining with non-specific IgG antibody as well as uninfected cell
cytosol containing no PICs. In addition, the nuclear pore blocking compound,
wheat-germ agglutinin (WGA), was included in some of the nuclear transport
assays, in order to show that PIC nuclear import is indeed conducted through the
NPC [shown in Figure 21].

VI. Vpr-GFP tagged IN NLS mutant viruses display decreased nuclear localization
The labeling of HIV virions via incorporation of fluorescently-tagged Vpr
molecules has previously been described [27,183]. In order to directly visualized
the sub-cellular localization of our NLS mutant virions during a live ongoing
infection, viral stocks of Vpr-GFP labeled virions containing these mutations in
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Figure 20. Digitonin-permeabilized macrophage nuclear import assay system reveals
excluded phenotypes for I N N L S mutant purified proteins. Primary h u m a n
macrophages were g r o w n on poly-L-lysine coated 1 2 m m round glass coverslips and
permeabilized with digitonin (see Methods). Cells were washed with IX transport
buffer to remove the cytosol, then a mixture containing xenopus oocyte cytoplasmic
extract, A T P energy source, R A N , GTP, and lug of purified H I V integrase w a s added
and cells were incubated at 37 degrees Celsius to allow nuclear import to occur. A ) A
diagram of the permeabilized cell system, followed by results of initial experiments
using purified W T I N from the pNL4-3 strain of H I V detected with an anti-IN
monoclonal antibody ( m A b 6 G 5 ) and a tyramide- FITC (green) kit. A G S T - G F P fusion
protein +/- the nucleoplasmin (NP) N L S w a s included as a control for nuclear import.
B) Wild type ( W T ) and K236/ 240A mutant purified IN proteins from the H I V IIIB strain
were added to transport reactions on permeabilized macrophages, and stained with
m A b 6 G 5 followed by a tyramide-Cy3 detector. The K236/240A mutant displayed a
nuclear exclusion phenotype w h e n compared to W T (white arrows) similar to that seen
in the e G F P - M B P fusion protein studies described previously. All cells were stained
with D A P I to visualize the nuclear D N A (blue). Cells were visualized at 100X
magnification on a DeltaVision microscope and each panel is representative of 30-50
permeabilized stained cells per field, four fields per slide, and three independent
experiments.
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I N were m a d e by co-transfection of these plasmids along with a plasmid
encoding the Vpr-GFP fusion protein in HEK 293T cells. Primary human
macrophages were seeded onto special Petri dishes (containing a single glass
microscope slide embedded in the middle), and GFP-tagged virions were
continuously visualized by live-cell imaging over a 16 hour period. Figure 22
shows still photos of macrophages infected with macrophage-tropic (Yu2 env)
wild type NLS (D116A mutant) and K236/240A NLS mutant viruses at 6 hours
post infection. The wild type NLS viruses clearly demonstrate a propensity to
congregate around the nucleus, a pattern which is evident as early as one hour

post infection and characterized by circular configurations of GFP-labeled virions
around the surface reminiscent of nuclear "rim staining" of nucleoporins like
Nup358 (see Fig. 21). Meanwhile, the K236/240A mutant virions did not display
the same pattern of nuclear localization in infected macrophages, with the
majority of the particles appearing scattered throughout the cytosol. Close
examination of time-lapse movies made from assembled images from the livecell infections [Figure 30, attached DVD] shows that, while many virions appear
to move towards the nucleus in the wild type NLS cultures, the Vpr-GFP
molecules never actually enter the nucleus per se, and the particles seem to
remain attached to the nucleus on the cyctoplasmic side.

84

anti-IN-FITC

DAPI

+anti-Nup358 qdot

Overlay

A.
WT

B.
WT
+
WGA

C.
IN
K236/240A

D.
IN
R262/3/6A

Figure 21. Digitonin-permeabilized macrophage nuclear import assay system reveals
excluded phenotypes for IN N L S mutant pre-integration complexes. Three million
macrophages were infected with a high M O I (100) of M-tropic HTV virus stock (wild
type R73-Yu2 and IN K236/240A as well as R262/3/6A N L S mutants). Twelve hours
following infection, a cytosolic extract was made from these infected cells and added to
donor-matched digitonin-permeabilized human macrophages. Immuno-histochemical
staining was performed using anti-integrase monoclonal antibodies (INT-2, iNT-4,
m A b 6 G 5 ) with a FITC-tyramide detector (green). Nuclear pores were stained with antiNup358 polyclonal rabbit antibodies (C-288 from E. Coutavas) coupled to an anti-rabbit
quantum dot 655 detector (red). Nuclei were stained with DAPI (blue) upon mounting.
A ) Wild type R73-Yu2 PICs. B) Wild type PICs + Wheat Germ Agglutinin ( W G A ) , which
blocks transport through nuclear pores. C) IN K236/240APICs. D ) IN R262/3/6 PICs.
Images were taken at 100X magnification, each one representative of 30-50
permeabilized stained cells per field, four fields per slide, in four independent
experiments.
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This observation is consistent with previous reports of the karyophilic
properties of the Vpr molecule itself [64, 184, 185], and the fact that the NLS
mutant Vpr-GFP mutants remained in the cytosol suggests that the NLS activity
in the integrase C-terminus may have hierarchical superiority over that conferred
by Vpr or other constituents of the PIC.
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Figure 22. Vpr-GFP tagged IN N L S mutants display decreased nuclear localization in
primary h u m a n macrophages. Vpr-GFP tagged virions were produced by double
transfection of 293 T cells with a plasmid encoding the Vpr-GFP fusion protein (T. Hope)
and a plasmid specifying an M-tropic Vpr-deficient HIV molecular clone (R73-Yu2deltaVpr). Primary human macrophages were then infected with these Vpr-GFP viruses
(+/- the IN K236/240A N L S mutation) at a high MOI, and cells were visualized at 6
hours post infection. A ) Representative cells (of 50-100 per slide) are shown for W T and
IN K236/240A Vpr-GFP infections with the nuclear D N A stained with D A P I (blue).
Individual PIC and PIC clusters are visible in green. B) Still photos from live-cell
imaging of HIV infection of macrophages. The nuclei in each field are indicated with
yellow arrows and GFP-tagged virions are shown in green. The D116A active site
mutant showed a nuclear localized phenotype than the K236/240A mutant, reinforcing
the importance of an intact IN C-terminus to nuclear import. Images are representative
of 30-50 Vpr-GFP positive cells per field, four fields per slide, in two independent
experiments.
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C h a p t e r a.. Stability a n d g e n e expression from u n i n t e g r a t e p
COVALENTLY-CLOSED CIRCULAR HIV-1 DNA

When the human immunodeficiency virus infects target cells HIV
integrase catalyzes the 3' processing and strand transfer reactions that are
necessary for viral replication. However, HIV Integrase-mediated insertion of
the proviral DNA into host chromosomal DNA is not absolute. It has been
known for over a decade that circular forms of viral DNA accumulate within

cells following infection with wild type HIV in vitro [186]. Yet, the role of thes
viral DNA circles in the life cycle of the human immunodeficiency virus has only
recently begun to be elucidated. Thus, understanding the potential role that
these viral DNA circles may play in supporting HIV infection and latency in
various cellular compartments is of key importance.
The accumulation of 1- and 2-LTR circles in monocyte-derived
macrophages and T cell lines following HIV infection with wild type virus in
vitro has been described [187]. Previous studies with integration-defective HIV
molecular clones and more recent studies with first-generation diketo acid HIV
integrase inhibitors have shown that 2-LTR circular forms of viral DNA

preferentially accumulate in T cell lines during infection with a catalytic triad
HIV integrase mutant virus or with wild type virus treated with HIV integrase
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inhibitors [175]. These episomal circular viral D N A s are capable of limited tat
and nef gene expression [41,187]. However, viral p24 gag gene expression from
2-LTR circles has never been documented. Accordingly, infection with
integration-defective catalytic triad mutant HIV molecular clones results in a
single-cycle non-productive infection in vitro.

During a productive HIV infection, antigen presenting cells including
dendritic cells and macrophages process viral protein antigens and present them
to T cells to initiate the antiviral immune response [reviewed in [188]].
However, the ability of viral proteins expressed from 2-LTR circles to stimulate
antiviral immune responses has not been ascertained. A recent report by Bakri et
al. describe the detection of 1- and 2-LTR circles in cultures of immature and
mature dendritic cells [189]. However, prior to the data presented in this thesis,
there have been no published accounts of long-term persistence or protein
expression from LTR circles from integration defective HIV viruses or HIV
vectors in myeloid-derived cells such as primary human macrophages or
immature dendritic cells.
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I. HIV-1 2-LTR circles are stable in primary h u m a n macrophages and immature dendritic

cells

Primary h u m a n macrophages were infected with wild type and D 1 1 6 A integrase
mutant HIV viruses or lentiviral vectors and total genomic DNA was isolated at
various times post infection. A diagram depicting how the D116A mutant
lentiviral vector was produced by alteration of the packaging plasmid R8.91

(kind gift of D. Trono) used in a triple transfection of HEK 293T cells [Figure 23
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Figure 23. P r o d u c t i o n of integration-defective lentiviral vector stocks. T h e D 1 1 6 A
m u t a t i o n w a s introduced into the pol reading f r a m e of the lentiviral vector p a c k a g i n g

plasmid pCMV-R8.2 (kind gift of D. Trono) to make pCMV-R8.2-D116A. The lentiviral
expression plasmid pHR' was then altered by the insertion of an expression cassette
encoding the gene for Secreted Alkaline Phosphatase (SEAP) (Clontech, Inc.) under the
control of the elongation factor 1 alpha (EF-1) promoter to make pHR'EF-1-SEAP.
SEAP-expressing non-integrating lentiviral vector stocks were produced by triple
transfection of the pCMV-R8.2-D116A plasmid along with the pHR'EF-1-SEAP and a
plasmid expressing the envelope protein from vestibular stomatitis virus (pMD.G).
These non-integrating lentiviral vectors were then used to transduce primary h u m a n
macrophages and SEAP production was measured at various time points posttransduction.
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A s expected, the D 1 1 6 A integrase mutant virus produced more 2-LTR circle
copies per cell compared to wild type HIV [Figure 24]. 2-LTR circle copy number
per genomic equivalent peaked after 24 hours in D116A infected macrophages,

while wild type circles peaked after 8 days. This difference in the rate of circle
formation between wild type and integrase mutant viral infections may be due to
the severity with which integration is disfavored with the D116A mutation,
determined by Wiskerchen and Muesing to be by as much as five to ten
thousand-fold [42]. There is no appreciable difference in the level of reverse
transcription between the wild type and D116A viruses, evidenced by the parity
of late RT products within infected macrophages. The decline of both late RT

products and 2-LTR circle copies with time coincides with increased cell death in
the macrophage cultures.

Primary human macrophages were infected with wild-type as well as
integration-defective (IN D116A) HIV-1 molecular clones, and total genomic
DNA was isolated from these cells at various times post-infection. We were able
to detect 2-LTR circles in macrophages from day 1 and up to 32 days post-

infection with the integration-defective HIV-1 viral species, but the circles were

barely measurable in the wild type infected cells at the latest time point [Figure
24a]. By day 32, the total number of both wild type and D116A integrase mutant
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analyzed for 2-LTR circle content via Real Time P C R . Peak copy numbers of 2-LTR
circles were reached by D a y 16 post-infection, with a 3 to 10-fold difference in 2-LTR
circle copies evident between the D 1 1 6 A IN mutant and the wild type R 7 / 3 virus.
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p24 G a g expression in primary h u m a n macrophages following infection

with wild type R7/3-Yu2 e G F P and D 1 1 6 A R7/3-Yu2 eGFP. Media samples were taken
at the various time points (as above) and analyzed via ELISA assay for p24 G a g
expression. The D 1 1 6 A mutant did not produce detectable levels of H I V gag, suggesting
that L T R circles alone are incapable of sustaining a viral infection.
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2-LTR circles decreased from peak levels (at day 16), which appears to correlate
with the gradual disappearance of cells due to cell death. While we consistently
observe a 10-fold elevation in 2-LTR circle copy number upon infection with the
D116A mutant virus, we were unable to detect viral p24 Gag expression from
macrophage cultures infected with the D116A integrase mutant virus [Figure

24b]. Thus, our data indicate that 2-LTR circles are stable for at least one month
in macrophages following infection with integration-defective HIV and they

appear to persist throughout the life of the cell. In similar experiments, primary
monocyte-derived immature dendritic cells were prepared as previously
described [190] and infected with wild type or D116A mutant HTV on day 6 of
the cultures. Infected cells were washed and total genomic DNA was isolated at
two time points at day 2 and 14 post-infection. Quantification of 2-LTR circles
present in the total genomic DNA samples from day 2 and Day 14 shows that the
circles persist in immature dendritic cells through Day 14 post-infection. The
D116A mutation produced a similar increase in circle copy numbers compared to
wild type controls as was seen in macrophage infections using these same

viruses.
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II. 2-LTR circles express low levels of enhanced green fluorescent protein (eGFP) in
macrophages

Low levels of viral gene expression were evident from unmodified 2-LTR
circles. Consistent with previous results, we were unable to detect viral p24 Gag
expression from macrophage cultures infected with the D116A mutant version of
R7/3, an HXB-2-derived proviral subclone of HIV-1 [191]. Similarly,
macrophages infected with an integration defective macrophage-tropic R7/3
variant, R7/3-Yu2-eGFP, which expresses the enhanced green fluorescent protein
gene from the ne/position, displayed markedly decreased levels of eGFP
compared to wild type controls [Figure 25]. The reasons for this lack of robust
gene expression from unintegrated viral DNA templates is unclear, and may be
caused by a variety of factors, including the supercoiled nature of the
circularized DNA, the proximity of circles to transcriptional machinery in the
nucleus, as well as the relative effectiveness of the viral 5' LTR promoter when
the HIV genome is in circular form. Indeed, the presence of two LTRs side by
side in the circularized viral DNA may cause promoter occlusion as an overload
of transcription factors and other molecules that bind to the sequences in the
LTRs could prevent the proper initiation of RNA polymerase II-mediated
elongation.
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III. Integration-defective VSV-G-pseudotyped lentiviral vectors express measurable levels
of secreted alkaline phosphatase (SEAP) in macrophages

In order to determine whether we could overcome possible negative

effects on the 5'LTR promoter in 2-LTR circles and thus increase the level of gen

expression from them, we constructed a series of lentiviral vectors that contained
an internal promoter, EF-la (elongation factor la), positioned downstream of the
LTR in the circularized viral DNA. The vectors were made integration defective
by way of a triple mutation of the catalytic residues (DDE motif, D64A, D116A,
E152A) [42] in the active site of the lentiviral integrase and addition of these
vector stocks to primary human macrophages resulted in non-productive, singlecycle infection with a characteristic increase of stable, unintegrated covalently
closed circular viral DNA. We inserted the gene for Secreted Alkaline
Phosphatase (SEAP) downstream of the EF-la promoter in order to serve as a
reporter for circle-driven gene expression. Following infection with EF-la-SEAP
2-LTR circle vectors, cells were washed thoroughly to remove non attached
virions from their surface, fresh media was added, and the cells were maintained
in culture for an additional seven days.
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R73-Yu2-eGFP
wild type

D 1 1 6 A IN

mutant

Uninfected Control

Figure 25. H I V 2-LTR circles express low levels of enhanced green fluorescent protein
(eGFP) in macrophages. Macrophages at day 21 following infection with either M-tropic
wild type R7/3-Yu2-eGFP (panel A), D116A -Yu2-eGFP integrase mutant HIV viruses
(panel B), or mock infected (panel C) are shown at 40X magnification. The D116A IN
mutant displayed low levels of eGFP expression when compared to wild type controls,
suggesting that 2-LTR circles are capable of limited gene expression in primary APC.
The data shown is representative of three independent experiments.
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Analysis of infected cell supernatants using an ELISA based assay to
detect SEAP, revealed that the insertion of a promoter (EF-la) internal to the 5'
LTR resulted LTR circle gene expression levels that were 25% of a wild type,
integration-competent vector with the analogous promoter/reporter combination
[Figure 26]. SEAP gene expression from the 2-LTR circle vectors peaked at 4
days, and did not decrease appreciably throughout the duration of the culture (8
days). The presence of 2-LTR circles and SEAP had no apparent deleterious
effects on cell viability in the infected cultures as determined by trypan blue
exclusion. This data suggests that, with the proper promoters, 2-LTR circle gene
expression can be moderately enhanced, and such modified lentiviral vectors
may represent a novel platform for gene therapy in non-dividing cells like
macrophages and imDC.
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Figure 26. Integration-defective V S V - g - p s e u d o t y p e d lentiviral vectors express
measurable levels of secreted alkaline phosphatase ( S E A P ) in m a c r o p h a g e s .
Lentiviral vectors w e r e engineered to b e integration-defective b y the introduction
of a n active site mutation ( D 1 1 6 A ) to the integrase portion of the pol reading
frame in the packaging plasmid. T h e vectors w e r e designed to express S E A P
u n d e r the control of the elongation factor la promoter (EF-1), pseudotyped with
the vesticular stomatitis virus envelope glycoprotein (VSV-g), a n d w e r e then
used to transduce primary h u m a n m a c r o p h a g e s at a n M O I of 10. After a 12 h o u r
incubation with vector, cells w e r e w a s h e d a n d fresh m e d i a w a s replaced in each
well. M e d i a w a s then collected at 4 days post transduction a n d analysed for
S E A P expression b y a chemiluminescent detection assay. M e d i a from the
w a s h e d cells as well as uninfected cells are included as controls. T h e data s h o w n
is representative of t w o separate experiments.
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Chapter 5. S u m m a r y and Conclusions

I. Lv-1 species-specific lentivirus restriction occurs at an early stage of the HI
during reverse transcription

Host cell factors that restrict murine retroviral infections have long been
known [154]. However, the existence of cellular factors that restrict lentiviral
infections in primates has only recently established. The data presented in

Chapter 2 of this thesis and in published form [149] represents the first definiti
example of a host cell activity that restricts the tropism of both HIV and SIV in
monkey and human cells. Analysis of viral DNA intermediates following
infection of both permissive and non-permissive primate cells revealed a striking

replication defect for incoming virions at the step of early reverse transcription
which carried through to subsequent steps of late reverse transcription, and

presumably affects nuclear import of restricted viral cores [Figure 11]. This host
cell factor was originally called Lvl (lentivirus susceptibility factor 1), but
subsequent studies have identified Lvl as the cellular molecule TRIM5-CX [165,
166]. Indeed, figure 2 of the report by Stremlau and colleagues describing the
identification of TRIM5-CX alpha as the lentivirus susceptibility factor shows a
defect in early reverse transcription for incoming HIV virions in rhesus macaque

100

cells containing high levels of rhesus TR1M5-CX that is analogous to the defect w e
observed in our initial experiments with Rh.F cells (also derived from macaque
monkeys). Thus, the results of our initial studies, in conjunction with supporting
reports from others, has now firmly established that the Lvl/TRIM5-cx host cell
restriction factor exerts its effects at the early stages of viral life cycle, at
following entry and prior to reverse transcription.
As mutations in the CA proteins of the incoming virions, as well as the
addition of saturating amounts of lentiviral particles can overcome the Lvl/

TRIM5-CX restriction [149,192], the most likely mechanism of action for this facto
is to bind to incoming virions in a manner that prevents CA disruption and
subsequent uncoating or the downstream formation of reverse transcription
complexes and functional PICs. While this proposed mechanism of action for
Lvl/TRIM5-(X has not yet been proven, several recent observations support this
assertion. First, the binding of the cellular protein Cycolphilin A (CypA) to HIV
capsids has been shown to protect incoming virions from the effects of Lvl /
TRIM5-CX in vitro [193]. Second, the CypA binding site in the CA protein
overlaps an important determinant of Lvl/TRIM5-cx restriction-factor
recognition in humans and nonhuman primates [193,194]. Notably, the
CA-CypA interaction is required for restriction of HIV-1 by certain nonhuman
primates, but in humans the CA-CypA interaction facilitates HIV-1 infection,
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presumably because it at least partially inhibits restriction factor
recognition[193]. Thus, the preponderance of evidence points to the lentiviral
CA protein as the main target for host cell restriction factors like Lvl/TRIM5-a.
An interesting recent observation of lentiviral restriction in New World
monkeys, such as the owl monkey (aotus trivirgatus), demonstrates the lengths to
which some host species go to generate host cell restriction factors to prevent
lentivirus infection. Sayah and colleagues [195] followed up on a previously
paradoxical observation that CypA-deficient HIV virions were able to overcome
the block to HIV infection in owl monkey (OMK) cells. Normally, CypA
incorporation into virions enhances their infectivity [reviewed in [164,196-200]
(presumably by protecting them from the binding of restriction factors, as
described above), so the result in OMK cells was surprising, and compounded by
the fact that reintroduction of CypA into these cells following CypA-specific
RNA knockdown by RNAi failed to restore the antiviral activity [195]. Instead it
was discovered that a hybrid molecule of TRIM5-(X and Cyclophilin, termed
TRIMCyp, had arisen in owl monkeys via retrotransposon-mediated insertion of
a cDNA containing CypA into the TRIM5-(X locus in the owl monkey genome as
they diverged from old world primates [195]. This molecule, and not the
traditional TRIM5-(X found in macaques (no TRIM5-isoform has yet been
identified in owl mokeys), is believed to be responsible for the species specific
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restriction of lentiviruses in these monkeys. Whether the exon shuffling that
produced TRIMCyp was purely serendipitous, or the result of evolutionary
pressure exerted by the hyper-infection of ancestral owl monkey populations
with pathogenic lentiviruses to which they were previously susceptible remains
unclear. Undoubtedly, future studies in this area will uncover some of the
molecular intricacies that vertebrates use to outmaneuver the pathogens that
infect them.

II. 2-LTR circles are stable in primary human macrophages and may be a platform for
gene therapy based vaccines

During Human Immunodeficiency Virus-type 1 (HIV-1) infection, the viral

integrase catalyzes a 3' OH processing reaction that serves to activate the linear
viral DNA termini for a subsequent strand-transfer reaction in which viral DNA
is covalently joined to the host chromosome. Sustained viral replication
absolutely requires the integration of the viral DNA since full transcription
competency is achieved only after the creation of the proviral state. However,
when the catalytic activity of integrase is compromised by small molecule
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inhibition or via specific point mutations in the catalytic core domain of the
enzyme, unintegrated viral DNAs accumulate in the nucleus in the form of 1LTR and 2-LTR covalently closed circles [42, 175]. These viral LTR circles were
believed previously to be labile byproducts of HIV infection[186], but our work
as well as other recent studies [41, 201] has shown that they are inherently
capable of limited expression of certain viral genes, namely tat and nef (as
evidenced by the expression of our in-frame nef-eGFP fusions shown in Figure
25). However, for reasons unknown, we were unable to demonstrate robust viral
gene expression from unintegrated circular viral DNA, and integration defective
viruses never produce detectable levels p24 gag expression within infected
macrophages. The inability of 2-LTR circles to produce enough viral protein to
sustain a persistent infection may be due to the inability of the major viral

promoter, the 5'LTR, to function outside of the context of an integrated provirus.
While other possible reasons for the reduction in gene expression from these

circles, such as the level of DNA supercoiling and the proximity to transcriptiona
machinery, cannot be ruled out entirely, the results of our experiments with the
EF-la-SEAP lentiviral vector system [Figure 26] suggest that the identity and/or
conformation of promoter used to drive gene expression from 2-LTR circles is an
important determinant of the amount of transcription they can support.
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A s the 2-LTR circles can easily be detected and quantified by real time
PCR in cultures of macrophages and T cells, numerous groups have sought to
use them as an indicator of recent HIV infection in order to glimpse the early

moments of the establishment of viral latency in these cells [202]. A recent report
by Sharkey et al. describing the persistence of episomal HIV intermediates in the
PBMCs of patients on highly active anti-retroviral therapy proposed that 2-LTR

circles can serve as a reliable marker of recently infected cells [203] . However,
our data showing long-term survival of 2-LTR circles in macrophage cultures, as
well as recent experiments from other groups showing the same in T cell lines,

refute this assertion [204]. Similarly, in SupTl and MT-4 T cell lines the slope of

the rate of decay of 2-LTR circles is very similar to the slope of the rate of cell

division, suggesting that the decline of 2-LTR circles is primarily due to dilutio
during cell growth instead of rapid decay upon recent infection [204]. In
addition, a recent study by Butler et al. showed that 2-LTR circles peaked in
abundance at 24 hours and persisted indefinitely in aphidicolin growth-arrested
SupTl cells, noting that declines in 2-LTR copy numbers in these cultures was
due to the death of infected cells [174, 205]. This result is similar to what we
observe in thirty-day macrophage cultures wherein 2-LTR circle copy numbers
decrease over time, apparently due to cell death. As these episomal viral
byproducts display a propensity to persist indefinitely inside of infected cells,
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and it would be difficult to separate cells that had been recently infected with
HIV from those that continuously harbored virus, we believe that measurment of
2-LTR circles would not be a reliable marker of recent HIV infection in vivo.

The data presented in this thesis indicates that 2-LTR circles persist until the
point of cell death in macrophages, following infection with wild type or
integration defective HIV. Using sensitive molecular beacon-based real time PCR
assays, we have tracked the appearance of viral DNA intermediates, including

early and late reverse transcription products, as well as 2-LTR circles at various
times post-infection. In addition, we monitored the capacity of integrationdefective HIV viruses to express the viral p24 Gag protein in antigen presenting
cells. We were able to enhance the level of gene expression to one-fourth that of
wild type by placing a defined promoter-driven transcriptional unit (EF-la-SEAP

cassette) in a location that would be internal with respect to the 5'LTR once the
LTR circles form in the nucleus. As these experiments were performed in a nondividing antigen presenting cell (macrophages), these results suggest that
lentiviral vectors modified to form 2-LTR circles may be worth exploring in gene
therapy settings. The non-toxic nature and persistence of such gene expression
episomes would avoid some of the pitfalls that have been seen with other
retrovirus-based gene therapy vectors, such as the insertional mutagenesis which
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lead to l y m p h o m a in patients treated with M L V vectors used in h u m a n clinical
trials for severe combined immunodeficiency syndrome [206-210]. Indeed, if a
sufficient level of continuous HIV gene expression from stable 2-LTR circle
templates is capable of priming anti-viral immune responses, then HIV integrase
inhibitors might have expanded immunological benefits in addition to their

ability to lower viral load. In addition, if additional alterations to 2-LTR circl

architecture (such as the inclusion of elements, like scaffold attachment regions,
that link them to areas of active gene transcription in the nucleus), can further

increase in their capacity to express genes, then non-integrating lentiviral vecto
systems may become the platform of choice for gene therapy applications in the
future.

III. The carboxyl terminus of HIV-1 integrase specifies a transferable nuclear localization
signal (IN NLS) that functions in primary cells

In previous studies, systematic mutagenic analysis was employed to
identify a potent nuclear localization signal (NLS) within the carboxyl-terminal
domain of HIV-1 integrase [167]. A region was identified spanning the chargedclusters of basic amino acids at residues 236/240 and 262/263/266 and
overlapping with a previously defined SH3 structural motif [168, 211, 212] that
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had profound effects on H I V I N import in the context of IN-eGFP fusion
proteins. In contrast to several earlier studies by others, we employed a novel,
codon-optimized version of HIV-1 integrase that enabled us to observe the effects
of NLS mutations on the nuclear accumulation of the native integrase protein. We
further demonstrated that the carboxyl-terminal NLS is transferable—when

fused in a variety of configurations to proteins that are otherwise cytoplasmic it
confers nuclear localization to the chimeric molecules. Importantly, this
transferable NLS was functional in non-dividing cells that support HIV infection
in vivo, such as immature dendritic cells and CD8-depleted (CD4+) peripheral
blood lymphocytes. That the IN NLS mutations prevented nuclear import of
large cargo proteins in non-dividing cells minimizes the possibility that they
simply coordinate integrase binding to chromosomal DNA.
Virions incorporating NLS mutations are intact with respect to integrase
catalytic function as well as to other biochemical parameters. However and more
importantly, a quantitative analysis of viral DNA intermediates formed during
infection of primary lymphocytes and macrophages (cell-types critical for the
propagation of HIV-1 in vivo) revealed a profound two- to three- log defect
specific to the nuclear import of mutant viral DNA. In addition, when these IN
NLS mutants were used to make fluorescently tagged Vpr-GFP virions, live cell
imaging of macrophage infections with these viruses reinforced the results
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obtained in the real time P C R and e G F P - M B P nucleofection experiments, as a
nuclear excluded phenotype was observed in cells infected with the IN NLS
mutant virus compared to the wild type IN NLS virus.
Interestingly, unlike canonical nuclear localization signals, the IN NLS
activity cannot be transferred as a small peptide unit but instead requires the
region of the protein spanning residues 220-270 [167]. When this region of HIV
integrase is dimerized in solution, each monomer adopts an SH3-like fold [211,
213]. In this configuration, a highly charged surface is created at the solvent
interface by the contribution of the basic residues at positions 236/240 and 262/
263/266, each cluster contributed by a separate monomeric unit. Thus,
orientation of the constituent residues of the IN NLS within the context of a

larger three-dimensional space may be critical to its function as a facilitator of
viral nuclear import. Although SH3 domains are not generally thought to interact
with the nuclear transport machinery, at least one example of this type of
interaction has been described. The SH3 domain of the human T-cell tyrosine

kinase, Itk, has been reported to interact directly with a karyopherin-a (Rchla) i
vivo and this interaction is necessary and sufficient for T-cell receptor signal-

regulated nuclear transport of the Itk protein [214, 215]. The fact that our mutan
are defective in dividing as well as non-diving cells is concordant with recent
data indicating that nuclear translocation of the HIV-1 genome is independent of
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mitotic nuclear disassembly [216]. In fact, these studies reveal that the nuclear
transport of viral DNA is actually delayed during as the cell undergoes mitosis
[216], a result previously unanticipated and widely thought to be
counterintuitive, as the nuclear membrane would be broken down during
mitosis and the virus should have free access to the nucleus under these
circumstances.

Similar to m a n y previously identified N L S sequences, the residues which
contribute to the integrase NLS are contiguous with, but distinct from, specific
residues important for DNA binding. Although basic residues are critical for NLS

activity, there is little homology to classic, bipartite, or basic NLSs such as th
nucleoplasmin (NP) and a karyophilic binding partner for integrase has not yet

been identified. In previous reports, Gallay and colleagues stated that HIV-1 IN i
brought to the nuclear pore through the interactions of karyopherin-alpha with
karyopherin-beta [217, 218]. However observations reported by Depienne et al.
[219] suggest that IN can dock at the nuclear pore and enter the nucleus in their
absence of these nuclear transport receptors. The basis for this discrepancy
remains to be determined, but is likely attributed to the difference in reagents

(specifically the type recombinant integrase proteins) used in the various studies
or the isotype of the karyopherins and other reagents used in the nuclear import
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assays. For example, the report by Depienne et al. relied u p o n a purified
integrase protein conjugated to a fluorescent molecule (Cy3). Their observation
that this fluorescently conjugated IN molecule can localize to the nucleus in the
absence of cytosolic factors (including the karyopherins) does not necessarily
prove their conclusion that IN mediated nuclear import is karyopherinindependent because the addition of the Cy3 moiety could affect IN
oligomerization, allowing it to passively diffuse through the NPC as a single
molecule (32kD, below the NPC exclusion limit) where it binds to DNA and

appears nuclear, or otherwise influence the trafficking of the native IN molecule.
In contrast to the Depienne et al. report, our results with the eGFP-MBP fusion
proteins suggest that the C-terminus of integrase must interact in some manner
with the host nuclear import machinery in order to carry this large protein cargo
through the NPC.
Additional support for the notion that integrase mediated nuclear import
involves host cells factors is found in three recent publications describing host
proteins that interact with HIV-1 integrase. These molecules include LEDGF
[220], importin7 [221] and EED [222] all of which have biochemical and
cytological characteristics that certainly warrant further investigation. LEDGF
and Importin7, have been shown to interact with HIV-1 integrase in a manner

that is consistent with either a role in the chromosomal targeting of the integras
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protein [220], or a function in the nuclear import of the viral R T complex itself
[221]. In the case of LEDGF, this interaction is dependent upon the aminoterminal and core domains of integrase, as the carboxyl-terminal domain is
reportedly dispensable for this interaction in vivo [220, 223]. However, our data

indicates that the IN C-terminal domain alone is both necessary and sufficient for

localization to the nucleus. A plausible explanation to reconcile these apparently
disparate results is that LEDGF simply anchors HIV-1 integrase to host
chromosomes after nuclear import has occurred, as the size of the HIV IN aminoterminalcore domain segment used in their experiments is roughly 23 kD, well
below the 60 kD exclusion limit of the nuclear pore.
Importin7 (an isoform of karyopherin oc) acts as a heterodimer with
importm-p* (karyopherin 3) to facilitate the nuclear import of histone HI [224],

certain ribosomal proteins [225, 226], as well as the RT complexes associated with
genomic HIV-1 import in permeabilized cells [221]. Although importin7 has been
reported to interact with the HIV-1 integrase protein in vitro, the experiments
performed to demonstrate this interaction required the addition of HeLa cell
cytoplasmic extract to the system in order to be detected [221]. Therefore, it is
possible that the contribution made by importin7 to nuclear import of RT

complexes may not result from its direct interaction with integrase per se, but is
instead coordinated through a complex of importin7/karyopherin (3, integrase,
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and some other as-yet-unidentified "bridging" molecule(s) in the cytosolic
extract. A good candidate for such a potential bridging molecule the is human
embryonic ectoderm development (EED) protein, which has been shown to bind
integrase in vitro [222]. Interestingly, EED also binds other HIV proteins, namely
Matrix and Nef [227, 228], suggesting that association with this cellular protein
may provide the virus with a replicative advantage.
EED belongs to the polycomb group of proteins (PcG) [229] that were
originally identified in Drosophila melanogaster as nuclear proteins containing
multiple copies of the WD-40 repeat [230] that act to remodel chromatin by

altering the accessibility of DNA to factors required for gene transcription [231].
Homologues of these proteins are highly conserved in mammals [232].
Significantly and quite unexpectedly (as integrase's toxicity to yeast cells has
confounded earlier attempts to define its binding partners) the EED protein has

been shown to interact strongly with the HIV-1 integrase protein in the context of
a yeast two-hybrid system [222]. This interaction appears specific for the
carboxyl-terminal domain of integrase. Perhaps most interestingly, the specific
binding between integrase and EED can be competed against in vitro with
recombinant bacteriophage that display peptide segments that map to the
identical set of charged-cluster amino acid residues that we have identified as
critical to integrase NLS function in vivo.
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In humans, a molecule that is homologous to drosophila E E D in both
DNA and amino acid sequence, has been described independently as a protein

that binds to the cytoplasmic domain of the integrin beta-7 subunit, alpha-4, beta
-7 [233]. This protein, designated WAIT-1 (WD-40 repeat protein Activated In TCells) was initially characterized in circulating lymphocytes where it appears to
be involved in the transduction of signals arising from the integrin beta-7
receptor [233]. In lymphocytes, signals arising from the integrin receptor are
thought to be transmitted via EED/WAIT-1 from the inner plasma membrane

into the nuclear compartment to affect regulation of inducible gene activity [233].
As would be expected for a protein involved in control of transcription, EED/
WAIT-1 is localized predominately to the nucleus in cycling cells as determined
by its fusion to a fluorescent indicator protein [234]. Thus, EED/WAIT-1 would
provide all of the essential features that incoming PIC, and the integrase Cterminal NLS contained within it, might desire in potential a binding partner,

including a propensity to rapidly localize to the nucleus in activated T cells, th
natural target cells for HIV infection in vivo.
Structurally, EED/WAIT-1 displays some features that would support its
potential role as a binding partner for our IN NLS during viral nuclear

translocation. Of particular interest is the proline-rich N-terminal region of the
proteins which harbors two closely spaced PXXP motifs—a motif commonly
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found

in inter- or intra-molecular interactions with S H 3

domains [235].

Interestingly, prolines at P60XXP63 in EED/WAIT-1 exist in the context of a
sequence known for other proteins to be utilized to coordinate SH3 domain
binding [236]. Finally, EED /WAIT-1 has been demonstrated to associate rapidly
with regions of the nuclear membrane near the nuclear pore complex following
infection with HIV-1 [222]. Importantly, integrase co-localizes with EED/WAIT-1

at the pore peaking at 6 hours post-infection, consistent with our results showing
that this same time frame is sufficient for nuclear localization of our Vpr-GFP
tagged viruses [see Figure 22] [222]. Future studies of HIV nuclear import
should seek to clarify the interactions between sequence motifs such as the Cterminal NLS in HIV IN described in this work, and soluble cellular factors such
as EED/WAIT-1 and karyophilic molecules like importin7. Generating a detailed
understanding of the molecular events and sequence motifs that support HIV's
specific nuclear import pathway will be vital to our ability to discover novel
antiviral compounds that block this critical step of the early viral life cycle.
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Future Studies:
I. Ligand blot methodology may reveal interactions between HIV integrase and host
factor(s) that facilitate viral nuclear import

Nuclear pore complexes can be isolated by biochemical means and
subjected to two-dimensional gel electrophoresis under denaturing conditions.

This results in a characteristic banding pattern of nuclear pore proteins that can
be transferred to nitrocellulose and probed by standard Western blotting
techniques. In order to discern whether a given recombinant protein or
multiprotein complex (i.e. an HIV PIC) is capable of binding to nuclear pore
proteins, one can use a solution of that protein in place of the primary antibody
to probe nuclear pore blots in a technique called ligand blotting [237, 238]. The
recombinant protein or complex could be used in isolation or in the presence of
specific cytosolic extracts containing requisite accessory factors (such as
karyopherins or other adaptor molecules) that facilitate nuclear pore protein

binding. This is followed by detection of the protein in question, in this case HI
integrase, with specific monoclonal antibodies, such as the mouse monoclonal
antibody 6G5, that is specific for the N-terminus of the enzyme. By using
recombinant HIV-1 integrase and PICs (both wild type and NLS mutant) on such
nuclear pore ligand blots in the presence of cytosolic extracts from various
primary cell types that naturally support HIV infection including activated CD4+
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T lymphocytes macrophages w e plan assess which nuclear pore components
bind HIV integrase in vitro. An example of a preliminary experiment using ligand
blot methodology with wild type and NLS mutant HIV PICs is shown in Figure
27. It appears that HIV integrase binds to numerous constituent proteins in the
rat liver nuclear pore complex including the lamins, histones, and possibly some
of the smaller nuceloporins. Future experiments are envisioned in which varying
concentrations of suspected integrase-binding adaptor molecules, such as EED
and LEDGF, as well as other viral proteins thought to be involved in nuclear
import (i.e. MA, Vpr), are titrated onto ligand blots to determine the extent of
their contribution to nuclear pore binding.

II. PIC immunoprecipitation may reveal differences in wild type and NLS mutant vir
interactions with FG nucleoporins in the NPC

Extraction of rat liver nuclei with the zwitterionic detergent, empigen, results i
an enrichment of some of the higher molecular weight constituents of the nuclear
pore complex. Large FG nucleoproins like Nup358, Nup214, and Nupl53 are
present in these empigen extracts, along with Nup62 and other FG nups [83].
When purified cytosolic extracts from HIV infected macrophages are added to
empigen extracted rat liver nuclei, it may be possible to discern differences
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between wild type and N L S mutant virions with respect to their ability to bind to
FG nups by attempting to immunoprecipitate bound FG nups with antibodies
specific for viral proteins, such as the anti-IN N-terminus monoclonal antibody
6G5. A diagram decribing the reparation of HIV pre-integration complexes
(PICs) is shown in Figure 28.
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Figure 27. Ligand blotting of rat liver Nuclear Pore Complexes with W T and N L S
mutant PICs. Rat liver nuclei were isolated, detergent solubilized, and run on a 4-20%
Tris-Glycine gel (2 units per well). Nuclear proteins including lamins, histones, and
nucleoporins were transferred to a nitrocellulose membrane by Western blotting and the
blot was cut into strips well by well. Each strip was placed in a well of an 8-well tray,
blocked with 3 % non-fat dry milk, and incubated for 2 hrs at room temp with purified
PICs from wild type and N L S mutant infected macrophages. A monoclonal antibody to
the N-terminus of IN was then added (mAb6G5) and detected with an anti-mouse HRPconjugated secondary antibody. Cytosolic extract from uninfected macrophages was
included as a control under the same staining conditions (lane 7). A ) Ligand blot of rat
liver N P C with HIV PICs reveals numerous nuclear proteins that are reactive with HIV
integrase. B) A stained blot of rat liver N P C with bands that have been identified by
mass spectometry [ref 119]. Comparison with the ligand blot suggests that HIV IN in the
context of PICs binds to histones (H2b, H2a, HI, and H4), lamins (lamin C), and perhaps
some smaller nucleoporins (Nup54, Nup45, and p42).
Data are representative of two
independent experiments.
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Figure 28.

Preparation of pre-integration complexes (PICs) from

HIV-infected

macrophages. Primary h u m a n macrophages were infected with high amounts of H I V
( M O I of 10,000), and infection w a s allowed to proceed for 6 hours at 37°C, to allow
reverse transcription and subsequent PIC complex formation. After 6 hours, infected
cells were washed twice with hypotonic lysis buffer, then incubated in ice-cold
hypotonic lysis buffer with 5 0 ^ g / m L digitonin detergent. Lysed cells were physically
disrupted by passaging through a 25-gauge blunt needle and syringe, then cytosolic and
nuclear extracts were m a d e according to the protocol found in the Materials & Methods
section. Cytosolic extracts were then snap frozen in liquid nitrogen then stored at -80°C
until use in digitonin-permeabilized cell assays.
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Figure 29 shows an example of an experiment in which PICs from cells
infected with wild type and NLS mutant viruses were incubated with empigenextracted rat liver FG nuceloporins and immunoprecipitated with an antiintegrase monoclonal antibody. Immunoprecipitated samples were separated on
a SDS-PAGE gel by electophoresis, transferred to nitrocellulose membrane, and
probed with an antibody specific for FG nucleoporins (mAb-414, courtesy of Dr.
Elias Coutavas, Blobel lab, Rockefeller U.) Small, FG nup antibody reactive
proteins are noticeable in the lanes containing wild type, D116A, and K236/240A
PICs that appear absent in the other NLS mutant PIC lanes (R262/3/6A and
260stop). These bands may be the result of a proteolytic activity that is
specifically active during wild type or K236/240A mutant infections that is
absent or inhibited in R262/3/6A and 260 stop infections. Or, they may represent
small FG nups that wild type virions (and K236/240 virions to a lesser extent)
bind to during viral nuclear import. Future studies are envisioned using this
PIC-empigen-extracted NPC immunoprecipitation assay in the presence of
different molecules, such as recombinant EED (or PXXP mutants of EED,
incapable of binding to HIV IN), as well as recombinant importin7 to reveal the
complexes interactions that likely occur between HIV PICs and the FG
nucleoporins during viral nuclear import.
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Figure 29. Immunoprecipitations with empigen-purified N P C and H I V PICs. Rat
liver nuclei were extracted with the zwitterionic detergent empigen to create an
enriched source of the higher molecular weight nucleoporins. Empigen purified
N P C were mixed with PICs from macrophages infected with wild type or N L S
mutant viruses, incubated for 2 hours at 4 degrees in the presence of protease
inhibitors and mild RIPA buffer, then immunoprecipitated with anti-integrase N terminus antibody m A b 6 G 5 and protein A sepharose. Immunoprecipitated
complexes were washed with buffer, heat denatured, run on 4-20% Tris-Glycine gel,
then blotted onto nitrocellulose.

The blot w a s then probed with m A b 4 1 4 , a

monoclonal antibody that is specific for FG-containing nucleoporins. A ) Western
blot of immunoprecipitated PICs /nucleoporins. Several diffuse smaller bands of
u n k n o w n identity are visible in the W T , D116A, and K236/240A wells. B) Western
blot of empigen extracted rat liver N P C probed with m A b 4 1 4 [ref 83]. C ) Schematic
diagram of the nucleoporins as they appear in the N P C [ref 122]. Data s h o w n are
representative of three independent experiments.
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chapter 6. Materials and Methods

Construction of Plasmids

EGFP-IN expression vectors contained the coding sequence for enhanced green
fluorescent protein (Clontech), upstream of an HIV-1 IN open reading frame
derived from the CXCR4-tropic, HXB-2 subclone, R73. This gene fusion was
cloned into pcDNA3.1 (+)-CTE, a derivative of pcDNA3.1 (+) (Invitrogen), that
includes the constitutive transport element (CTE) from Mason-Pfizer monkey
virus. A synthetic, codon-modified IN gene, IN-MOD (GenBank Accession
#AF422697), was constructed by primer extension of overlapping 100 base-pair
oligo-nucleotide segments and cloned into pcDNA3.1 (+)-CTE to create the
modified integrase expression plasmid, pcDNA3.1 (+) IN-MOD-CTE. The natural
version of the viral integrase gene from R73, IN-VIR, was cloned into pcDNA3.1
(+)-CTE to create the cognate, viral integrase expression vector, pcDNA3.1 (+)
IN-VIR-CTE. These plasmids are identical except for the segment encoding the
wild-type integrase amino acid sequence. For the plasmids used in the eGFPMBP-IN NLS transfection and nucleofection studies, the C-terminal portion of
the IN MOD gene was amplified by PCR and inserted at the C-terminal end of a
gene encoding an enhanced green fluorescent protein (eGFP)-maltose binding
protein (MBP) fusion protein in the context of a CMV expression vector plasmid.
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For viral studies, the relevant mutations were subcloned into derivatives of R73.
In some cases, the envelope gene of R73 was replaced with that of the
macrophage-tropic primary isolate, R73(YU-2).

Preparation of Primary Immune cell populations

Immature Dendritic Cells
Primary human immature dendritic cells were prepared by CD14+ magnetic
bead separation of CD 14+ monocytes from peripheral blood mononuclear cells
(PBMCs) obtained from blood donors. In general, 50ml of a human leukocyte
concentrate (from 500ml of whole blood, LEUKOPAK (from the New York Blood
Center) is mixed 1:1 with IX phosphate buffered saline (PBS) in a T75 culture
flask. Approximately 33ml of this 1:1 PBS:Blood mixture is layered onto 10ml of
Ficoll paque (Pharmacia) into each of three 50ml Falcon polypropylene tubes,
then tubes are centrifuged at 2000 rpm for 20 minutes at room temperature with
the brake off. Following this centrifugation step, a layer of PBMCs is visable in
each tube between the plasma (top) and red blood cells (bottom). This layer of
PBMCs is collected from each tube and placed in a fresh 50ml Falcon tube then
the volume is adjusted to 50ml with PBS. Cells are then centrifuged at 1200 rpm
for 10 minutes at 4°C to pellet the PBMCs. The PBMC pellet is then resuspended
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in 3ml of A C K red blood cell lysis buffer (Bio-Whittaker) and incubated at room
temperature for 5 minutes. The volume is then adjusted to 50ml with cold PBS

and the cells are centrifuged at 1200 rpm for 10 minutes at 4°C to pellet. Cells a
then resuspended and washed with 50ml cold PBS two more times. A lO^il
aliquot was taken before the final centrifugation, added to lOul of trypan blue
solution (Cellgro) on a piece of parafilm, then added to a hemocytomer for cell
counting while the tube of PBMCs is spinning.
The PBMC pellet was then resuspended in MACS buffer (0.5% Bovine Serum
Albumin/PBS) by adding 80^1 of MACS buffer per 1 x IO7 PBMCs. CD14+
magnetic beads (Miltenyi Biotech) were added at lOul per 1 x IO7 cells, mixed by
pipetting and stored at 4°C for 20 minutes to allow for binding. Cells were then
washed by adding 20-fold increase of volume of MACS buffer, then
centrifugation at 1200 rpm. CD14+ labeled PBMCs were then resuspended in
lml of cold MACS buffer, and added to a washed (with 5ml of cold MACS
buffer) LS magnetic column mounted on a mini-MACS magnetic stand (Miltenyi
Biotech). Cells were allowed to flow through by gravity then the column was
washed twice with 5ml of MACS buffer. The CD14- fraction (flow through) was
collected and saved for the preparation of CD4+ T cells (see below). The CD14+
monocytes were collected by removing the LS column from the magnet, adding
5ml of MACS buffer, then pushing the cells through with a plunger into a 15ml
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Falcon tube. Aliquots (lOul) were taken for counting, and cells were centrifuged
at 1200 rpm for 10 minutes at 4°C.
CD14+ monocytes were resuspended at a concentration of 1 x 106 cells/ml in cell
culture medium, supplemented with cytokines. The cell culture medium used
throughout was complete RPMI 1640 (Cellgro) supplemented with 2mM Lglutamine (GIBCO-BRL Life Technologies), 50|JM 2-mercaptoethanol (Sigma),
lOmM HEPES (GIBCO-BRL Life Technologies), penicillin (100 U/ml)streptomycin (100Mg/ml) (GIBCO-BRL Life Technologies), and 1% heparinized
human plasma (Rl media). Recombinant human (rh) IL-4, was purchased from
R&D Systems and used at a final concentration of 100 Units/ml, recombinant
human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was
bought from Immunex and used at a final concentration of lOOOU/ml. Every two
days, 200|jl of fresh Rl media was added to each well supplemented with GMCSF (1000 U/ml) and IL-4 (100 U/ml). Immature dendritic cells were then
harvested between days 6-8, and a small aliquot was removed for FACs analysis.

C D 4 + T cells
Primary human CD4+ T cells were isolated by negative selection using the CD14PBL fractions from the immature DC preps described above. Briefly, a cocktail of
antibody-conjugated magnetic beads (Miltenyi Biotech) was added to CD14-

126

PBLs which include: anti-CD8 (removes C D 8 + CTLs), anti-HLA-DR (removes
residual APCs), anti-CDllb (removes monocytes and granulocytes), and antiCD19 (removes B cells). The magnetic beads were added at an equal fraction
based on the parameters described above (lOpil of each type per IO7 CD14- cells).
Cells were incubated with beads for 20 minutes at 4°C, then washed by adding
20-fold increase of volume of MACS buffer, then centrifugation at 1200 rpm.
CD4+ T cells were negatively selected by adding them to and collecting the flow
through from a LS column attached to a miniMACS magnet as described above.
CD4+ T cells were then pelleted by centrifugation at 1200rpm for 10 minutes.

After centrifugation, cells were resuspended at high density (1 x IO7 cells/ml) in
Rl media supplemented with 5ng/ml of recombinant human IL-2 (Boehringer
Mannheim) and maintained in culture with fresh media added every 2 days until

use.

Macrophages
Primary human macrophages were derived from the same CD14+ monocyte
populations used to make immature DC above. Briefly, CD14+ monocytes were
resuspended in Rl media and plated at 1 x IO5 cells per cm2 in 24-well tissue
culture plates containing round 12 mm glass slides (Fisher Scientific) that had
been treated beforehand with poly-L-lysine (Sigma), for 20 minutes at room
temperature, then washed twice with PBS. Monocytes were incubated in a 37°C
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incubator with 5 % C O 2 for six to seven days, then the Rl media w a s removed
and replaced with fresh Dulbecco's Modified Eagle Medium (DMEM, Cellgro),
supplemented with 10% Fetal Bovine Serum (FBS, Cellgro).

FACS analysis of Primary Immune cells

Phenotyping of immature dendritic cells

For FACs analysis of primary human immature dendritic cells, 2xl04 DCs per
well of a 96-well V-bottomed plate (100u4 per well). Huorescently-labeled
antibodies were added at the following concentrations per lOOul cells: IgGlPE(l:
50), IgG2bPE (1:50), IgG2a-FITC(l:200) controls, IgGIPE (1:50), IgG2bPE (1:50),
HLA-DR-FITC (1:200), CD25-PE(1:50)/HLA-DR-FITC(1:200), CD80-PE(1:50)/
HLA-DR-FITC, CD83-PE (1:50) (Immunotech) / HLA-DR-FITC, and CD86-PE (1:
50)/HLA-DR-FITC. FITC and PE-conjugated antibodies were from BD
Pharmingen unless otherwise noted. The V-bottomed plate was then covered
with aluminum foil and incubated for 20 minutes (or overnight) at 4°C in the
dark in a refrigerator. After incubating with antibodies, 100u4 of FACS wash
(PBS/5% FCS/0.1% Azide) was added, and mixed by pipetting. Then the cells in
each well were pelleted by centrifuging the plate for 2-3 minutes at ~2500rpm.
Aspirated off approximately half of the volume, added 100|jl of FACS wash,
centrifuge at the above time and speed and repeat twice more (4 spins in total
After the 4th spin, aspirate of half of the volume and add 100|jl of FACS fix (10%
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formalin in PBS). Store the fixed, stained cells in the fridge (covered in foil) until
ready to analyze on FACs Calibur fluorescence-activated cell sorter (Becton
Dickinson). The cells were acquired (5-10,000 events), gating on large DCs and
the HLA-DR+ cells were assessed. Immature DCs are HLA-DR+ and express
moderate CD86 and at best low levels of CD80, while CD25 and CD83 are
typically not expressed on the immature DC surface (CD83 is expressed
intracellularly). All of the DC used in the nucleofection and other experiments
described in this thesis were of the immature phenotype.

Phenotyping ofCD4+ T cells
FACs analysis of CD4+ T cells was performed in the same manner as for the
immature dendritic cells described above, with the exception that different
antibodies were used for staining. Briefly, CD4+ T cells were stained with the
same controls: IgGlPE(l:50), IgG2bPE (1:50), IgG2a-FITC(l:200), IgGIPE (1:50),
IgG2bPE (1:50), and the following specific antibodies, along with a constant CD3FITC-labeled antibody: CD4-PE(1:50)/CD3-FITC(1:50), CD8-PE(1:50)/CD3-FITC,
CDllb-PE(l:50)/CD3-FITC, CD14-PE(1:50)/CD3-FITC, CD25-PE(1:50)/CD3-FITC,
CD38-APC(CalTag)(l:50)/CD3-FITC, and CD69-PE(1:20)/FITC. FACS analysis was

performed as above on the FACs Calibur sorter gating on small CD3+ T cells (5-10,0
events). The CD4+ cells used in the nucleofection experiments were CD4-high, CD8-
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negative, CD14-negative, CD25-low, CD38-low, and CD69-low, indicating a naive C D 4 +
T cell phenotype.

Cell Culture, Transfections, Nucleofections, and Virus Production

HEK293T and CEM-SS cells were maintained in the appropriate media (DMEM
(Cellgro) supplemented with 10% Fetal Bovine Serum (Cellgro). Macrophages
were prepared by monocyte isolation from the peripheral blood mononuclear
cells (PBMC) of normal blood donors either by density gradient centrifugation on
46% Percoll (Amersham Pharmacia Biotech), followed by plastic adherence for 1
hour at 37°C and culture for 6 days in RPMI-1640 with 2% Human AB serum
(Sigma) or by CD14-magnetic bead cell sorting (MACS procedure, Miltenyi
Biotech, described above) before infection. For primary dendritic cells and CD4+
T cells, ficoll purified PBMCs were incubated with CD14-specific microbeads
(Miltenyi Biotech) and CD14+ monocytes were isolated over LS columns
according to the manufacturer's protocol. These CD14+ monocytes were
cultured in GM-CSF (100 U/ml) and IL-4 (10 U/ml) for 6 days, with fresh
cytokines and media added every two days until cells resembled immature
dendritic cells on FACS analysis as described above. Activated CD8-depleted
peripheral blood leukocytes (PBL) were generated from the same donor-matched

130

P B M C samples used to prepare the macrophages, by removing C D 8 positive cells
from the CD14- fractions remaining after monocyte removal with anti-CD8
magnetic beads according to the manufacturer's protocol (Dynal, Inc.). All viral
stocks were prepared in transfected 293T cells filtered through 0.45 mm filters
and treated with DNase I (Sigma) at 8 mg/ml for 30 minutes at 37°C.

Nucleofection with AMAXA kit
For nucleofection experiments, the remaining, CD14- cells were subjected to
further purification using magnetic beads specific for HLA-DR, CDllb, CD19,
and CD8 and a population of approximately 96% (by FACS) pure CD4+ T cells
was isolated and cultured at high density (1 x IO7 per ml) in media supplemented
with 5ng/ml recombinant human IL-2. At day six of each culture, cells were
collected, pelleted by centrifugation, and resuspended to 2.5 x IO5 cells/ml in
either T cell nucleofection solution (AMAXA Biotech) or dendritic cell
nucleofection solution depending on the cell type. One hundred microliters of
either cell suspension was mixed with 5|Jg of each eGFP-MBP-IN plasmid DNA

in a microfuge tube, then transferred to a specialized electroporation cuvette and
placed in the nucleofection device using program U-14 or U-02 according to the
manufacturer's protocol (AMAXA Biotech). Nucleofected cells were
immediately re-equilabrated in warm (37°C) media and incubated at 37°C with
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5 % C O 2 for 12 hours. After 12 hours, cell aliquots from each condition were
taken and adhered (in serum free media, lOOpl cells/slide) to alcian blue/poly-Llysine (Sigma) coated 12 mm circular glass slides (Fisher Scientific), then fixed
with 4% paraformaldehyde (Tusoumis), permeabilized with 0.1% Trition-XlOO /
PBS (Sigma), washed 3 times with PBS, and mounted with DAPI containing
mounting medium (Vectashield). In some experiments, nucleofected CD4+ T
cells were sorted for GFP expression (Peter Lopez, AD ARC Mo-Flo facility) and a
more concentrated population of nucleofected T cells were used to make slides
for analysis on Delta Vision. This resulted in clearer microscope images, as much
of the post-nucleofection dead cell debris was removed by the sorting.

Generation of HIV Virus and Lentiviral Vector Stocks

All virus and lentiviral vector stocks were generated by transient transfection fo
plasmid DNAs into HEK 293T cells. Briefly, 4 x IO6 cells were seeded into 75 cm2
tissue culture flasks (Falcon BD). After 12-16 hours, a transfection mixture
containing viral DNA (10|Jg of each HIV R73 plasmid DNA), the cationic lipid
DMRIE-C (30ul) (Invitrogen), and Opti-MEM media (6ml) (Invitrogen) was
added to the cells and allowed to incubate on cells for 16-24 hours. Transfection
mixture was then removed and fresh DMEM-10% FBS media was added back to
the transfected cells. Cell supernatants containing virions were harvested at 24
-48 hours later, filtered through 0.45 urn syringe filter (Millipore), and stored
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frozen in 1ml aliquots at -80°C until use. In the case of lentiviral vector stocks,
10|Jg of an expression plasmid, 15[Jg of a packaging plasmid, and 5pig of a VSV-g
envelope plasmid, and 50^1 DMRIE-C were co-transfected under the same
conditions as above. For generating the Vpr-GFP HIV virus stocks, 10ng of a
Vpr- HIV-R73-Yu2 molecular clone plasmid DNA was added with 5ug of a
plasmid specifying a Vpr-GFP fusion protein (kind gift of Dr. Tom Hope,
University of Chicago), along with 30 nl of DMRIE-C reagent in 6ml total volume
of Opti-MEM, and transfection of 293T cells was performed as described above.
For the still images shown in Figure 22, 500ng p24 was added to each well of
macrophages in a 24-well plate (at an approximate MOI 10,000).

Real-Time PCR Assays

The PCR primers used to amplify and detect the various viral DNA
intermediates are described below and their coordinates within the R73 plasmid
used in these experiments is indicated.

Early reverse transcription assay—forward primer:
5'-TCTCTGGCTAACTAGGGAACCCACTGCTT-3'(bpl81-209 in R region of

LTR), 491-519 in R73
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reverse primer: 5 ' - T G A C T A A A A G G G T C T G A G G G A T C T C T A G T T A C C A G - 3 ' ,
(bp271-302 in U5 region of LTR) 581-613 in R73 molecular beacon: 56-FAM-5'CCGAACCAGTAGTGTGTGCCCGTCTGTTGTGTGGTTCGG-3'-Dabcyl(bp243
-266 in U5 region of LTR) 552-576 in R73

Late reverse transcription assay—forward primer:
5'-AGATCCCTCAGACCCTTTTAGTCAGTGTGG-3'(592-621),
reverse primer: 5'-GCCGCCCCTCGCCTCTTG-3', (721-738)
beacon: 56-FAM-5'-CCGACCCTCTCGACGCAGGACTCGGCTTGGGTCGG-3'Dabcyl. 684-705

2-LTR circle assay—forward primer:
5'-CTCAGACCCTTTTAGTCAGTGTGGAAAATCTCTA-3', reverse primer: 5'TGACCCCTGGCCCTGGTGTGTAG-3', beacon: 56-FAM-5'CCGCACCTACCACACACAAGGCTACTTCGTGCGG-3'-Dabcyl. 53-74 in R73

CCR5 assay—forward primer:
5'-TCATTACACCTGCAGCTCTCATTTTCCATACAGTC-3',
reverse primer: 5'-CACCGAAGCAGAGTTTTTAGGATTCCCGAGTA-3',
beacon: 56-FAM-5'-GCGCCTATGACAAGCAGCGGCAGGAGGCGC-3'-Dabcyl.
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Contamination control -forward primer:
5'- TACTCTAAACCTGTGATTCCTC-3' 119-140 in R73 plasmid "backbone"
reverse primer: 5'-TGACCCCTGGCCCTGGTGTGTAG-3', 289-311
beacon: 56-FAM-5'-CCGCACCTACCACACACAAGGCTACTTCGTGCGG-3'Dabcyl.

For each reaction, five microliters (approximately lOOng) of total genomic DNA
was added to 45\iL of PCR mastermix containing IX PCR buffer II (Perkin
Elmer), IX ROX internal passive reference buffer, 200nM dNTPs, 400 nM
primers, 200nM molecular beacon, and 1 U AmpliTaq Gold (Perkin Elmer) in

each well of a 96-well PCR reaction plate. After an initial denaturation step (94°
for 10 minutes), PCR amplification proceeded for 50 cycles (94°C for 15 sec; 60°C
for 30 sec; 72°C for 30 sec) in a Perkin Elmer ABI Prism 7700 sequence detection
system. Copy numbers for all samples were determined by extrapolation from a
plot of PCR standards using the ABI Prism 7700 SDS quantification software.

Immunocytochemistry and Basic Fluorescence Microscopy

Cells were grown on poly-L-lysine (Sigma)-treated glass coverslips. After
transfection, cells were fixed with 3% electron-microscopy grade paraformaldehyde (Tosoumis) in PBS, and, in some cases, stained using mouse
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monoclonal antibodies to IN (generally m A b 6 G 5 , N I H A I D S reagent repository),
and either a tyramide-based amplification with anti-HRP antibodies (TSA kit,
AppliedBiosystems) or, in the case of Nup358 staining, a biotinylated anti-rabbit
antibody conjugated to a streptavidin-linked quantum dot 655 (qDots Inc).
Coverslips were mounted in medium containing DAPI (Vectashield, Vector
Laboratories). EGFP, DAPI and antibody fluorescence were visualized using
deconvolution, restoration microscopy (DeltaVision, Applied Precision). In the

case of nucleofected cells, dendritic cells and T cells were resuspended in serumfree RPMI (lOOul) and adhered to alcian blue coated glass coverslips for 5
minutes at 37°C, then 2 minutes at 4°C, fix with 3% paraformaldehyde, and
inverted onto glass slides with DAPI containing mounting medium (Vectashield).

Viral Infections

Macrophage and PBL infections
Virus was added to confluent a monolayer of macrophage (approximately 2.0 x
IO5 cells) or activated PBLs (1.0 x IO6) in 24-well format and infection enhanced
by spinoculation. Briefly, the technique of spinoculation involves spinning the
virus particles (in media containing Fetal Bovine Serum) down onto the
monolayer of macrophages or other cells by centrifugation for 90 minutes at 2300
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r p m at room temperature. This technique increases the amount of virus that
contacts the cell surface and enhances the rate of infection in the cultures.
Generally cells were infected with between 250-50ng p24 of HIV viruses or
lentiviral vector stocks, with no large differences apparent in downstream assays
(i.e. Real Time PCR) when the spinoculation technique was used. Following
spinoculation, infected cells were washed thoroughly (at least 3 times) with PBS
to remove free virions and excess contaminating viral DNA from the transfected
stocks. Fresh media was added back to all washed infected cells. Inhibitors used
include lOmM UC78154 (in PBS), 5mM L-731,988 (in DMSO) . Total nucleic acid
was obtained using the QIAmp Blood Kit according to the manufacturer's
protocol (Qiagen).

Digitonin-permeabilized macrophage nuclear import assays

Primary human macrophages were grown on glass coverslips in 24-well tissue
culture plates. Cells were washed twice with ice-cold IX transport buffer (20mM
HEPES, HOmM potassium acetate, 2mM magnesium acetate, and 0.5mM EGTA)
with IX protease inhibitors (EDTA-free mini complete tablets, Roche), and then
permeabilized for 5 minutes on ice in transport buffer containing 45|Jg/ml highpurity digitonin (Calbiochem). After one wash in transport buffer, slides (with
permeabilized macrophages) were removed from the wells of the tissue culture

137

plate and inverted onto 30ul nuclear import reactions containing lOul cell extract
(from Xenopus oocytes or HeLa cells), l[il of 20X stock of an energy-regenerating
system (ImM ATP, ImM GTP, 2mM creatine phosphate, 40 U/ml creatine
phosphokinase), lpil of lOmM GTP, 1|jM of recombinant protein of interest (or
lOul PICs), and lu4 of recombinant Ran. Nuclear import reactions were
incubated at 37°C for 2 hours, then cells were washed twice with IX transport
buffer, once in PBS, fixed with 3% PFA and immunostained and visualized as
described above.

PIC Immunoprecipitations

To generate PIC from infected macrophage cytosol, three million monocytes were
plated in T25 flasks (Falcon), incubated at 37°C for six days in Rl media, and
media was changed to DMEM/ 10%FBS on day 7. In a Biosafety Level 2+ facility
and inside of a tissue culture hood, primary human macrophages were infected
with 3|Jg R73-Yu2 virus stock in 3ml culture media, and incubated for 12 hours,
to allow reverse transcription to occur. Then, virus was washed off of cells with
PBS (a total of 4 washes, 6ml volume per wash), and cells were incubated in 3ml
hypotonic lysis buffer A (lOmM HEPES, 1.5mM MgC12, 5mM KCI, 5mM DTT, IX
protease inhibitors, and 50ug/ml digitonin (CalbioChem)) for 1 minute, then
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buffer w a s removed, and 1ml of hypotonic lysis buffer A w a s added back to the
infected cells. The flask was then incubated on ice for 30 minutes, then lysed

cells were removed from the flask with a cell scraper, and the 1ml of infected cel
lysate was collected in a 1.5ml microfuge tube. A small piece of parafilm was
placed over the mouth of the tube to reduce aerosol formation. The infected cell
lysate was then homogenized by passing it through a blunt-ended 23 gauge
needle attached to a 1 cc syringe for 5-10 minutes (about 50-100 times). The
homogenized lysate was then centrifuged at 6000 rpm for 5 minutes at 4°C to
pellet the cell nuclei. The supernatant was removed, placed in a new tube, and
centrifuged at 10,000 rpm for 10 minutes at 4°C. The clarified supernatant

("PICs") was then collected and stored in 100ul aliquots in a -80°C freezer until

use.
Empigen-extracted rat liver nucleoporins were m a d e by detergent solubilization
of rat liver nuclear envelopes obtained from Elias Coutavas in the Blobel lab
(prepared as previously described by Blobel and Potter, 1966). Briefly, three
hundred million nuclei were thawed and pelleted at 3000 rpm for 1 minute.
Pelleted nuclei were resuspended with constant vortexing at a final concentration
of 100 U/ml 1 by drop-wise addition of buffer A (O.lmM MgCi2, ImM DTT,
0.5mM PMSF, 1 Mg/ml_1 leupeptin/pepstatin/aprotinin) supplemented with
5ug/mH DNase I and Sug/mF RNase A. After resuspension, nuclei were
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immediately diluted to 20 U / m h 1 by addition of buffer B (buffer A 1 0 % sucrose,
20mM triethanolamine, pH 8.5) with constant vortexing. After digestion at room
temperature for 15 minutes, the suspension was underlayed with 4ml ice-cold
buffer C (buffer A 30% sucrose, 20mM triethanolamine, pH 7.5) and centrifuged

at 3,500 g for 10 minutes in a swinging bucket rotor (Sorvall SH-3000). The pellet
was resuspended in ice-cold buffer D (buffer A 10% sucrose, 20mM
triethanolamine, pH 7.5) at a final concentration of 100 U/ml-1. The suspension
was diluted to 67 U/mL1 with buffer D 0.3 mg/ml-1 heparin (Sigma), and then
immediately underlayed and pelleted as above. The heparin pellet was
resuspended in ice-cold buffer D (100 U/ ml-1), diluted to 67 U/ ml-1 with buffer
D+3% Triton X-100 (Sigma), and 0.075% SDS, then pelleted as above. The pellet
(the NPC-lamina fraction) was then resuspended in buffer D+0.3% Empigen
(CalbioChem) (final concentration of 100 U/ml-1). After incubation on ice for 10
minutes, the insoluble lamina was separated from soluble nucleoporins by
centrifugation in a microfuge at 12,000 rpm for 15 minutes. The supernatant,
containing the Empigen-extracted rat liver nucleoporins was then collected, snap
frozen in liquid nitrogen, and stored in 100ul aliquots at -80°C until use.

For the immunoprecipitations, lOOtil of thawed PICs was added to lOOul of
Empigen-extracted rat liver nuclei. This mixture was then used "pre-cleared"
with Protein A/G sepharose beads (Santa Cruz Biotech) by adding 20nl of beads
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per 200ul of sample, incubating at 4°C on a rotator, then centrigufing at
14,000rpm for 1 minute. Monoclonal antibodies to the N-terminus of HIV
integrase (1:100 dilution of mAb-6G5, NIH AIDS repository) were then added to
each sample, along with 20ul of PBS-washed Protein A/G beads.
Immunoprecipitation reactions were incubated at 4°C for 3 hours on a rotator,
then beads were harvested by centrifugation at 14,000 rpm for 1 minute. The
beads were washed six times with 400 ul of IP buffer (IX Tris-buffered saline
(TBS) + IX protease inhibitors + O.lmM MgCl2), then 50ul of 2X Laemmli sample
buffer (BioRad, supplemented with ImM DTT) was added to each sample, then
tubes were incubated at 95°C for 5 minutes on a heat block. Samples were then
electrophoresed on 4-20% Tris-Glycine gels (Invitrogen), transferred onto
nitrocellulose (Amersham), and analysed by standard western blotting
procedures (IX Tris-Glycine transfer buffer, with 10% methanol and 0.1% SDS,
Invitrogen, then transferred for 2 hours at a constant 30V) using the anti-FG
nucleoporin monoclonal antibody mAb-414 from the Blobel lab (1:2000 dilution).

Ligand blot assays

For the ligand blot assays, 1 x IO6 rat liver nuclei were run out in each well of a
15-well 4-20% Tris-Glycine gel, then transferred to nitrocellulose by western
blotting as above. The blot was then blocked for 1 hour with 3% non-fat dry milk
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(BioRad) and then cut by well into 15 strips. Each strip w a s air-dried, then added
face up to each well of an 8-well plate (Costar). Using both wild type and NLS
mutant version of recombinant HIV integrase (kindly provided by Dr. Daria
Hazuda, Merck & Co., Inc.) at a final concentration of luM per well, 1ml of
recombinant protein solution was added to each strip. The strips were then
washed six times with 2ml of IP buffer, and incubated for 1 hour at room
temperature with 1ml of a 1:500 dilution of mAb-6G5 also in IP buffer. The strips
were then washed again, and incubated for 30 minutes with a goat-anti-mousehorseradish peroxidase-conjugated secondary antibody (Pharmacia) at a 1:40,000
dilution. Bound HIV integrase was then detected by developing the strips with
the Super-signal West-Pico HRP substrate reagent (Pierce), according to the
manufacturer's protocol.

Live-Cell Imaging with Vpr-GFP viruses

Primary human macrophages were grown in special Petri dishes with embedded
glass slides (Matek, Inc.). Prior to addition of Vpr-virus stocks (made in HEK

293T cells as above, by co-transfecting viral constructs lacking the Vpr gene with
plasmids encoding Vpr-GFP), the Petri dish of macrophages was mounted onto
an Axioplan microscope (Zeiss) equipped with a spinning-disk laser confocal set
up and a heated chamber (37°C). D116A and K236/240A NLS mutant viruses
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were added (3ug p24 of each virus, 3ml total volume, approximate M O I of
10,000) and focus was adjusted until optimal fields of virions and cells were
attained. Once an optimal field was identified, the microscope software was
programmed to image the cells over a defined duration (16 hours) at 5-minute

intervals through a range of Z series positions through the cell. At the end of th
16-hour infection period, images from the middle section of the Z series
(representing the center of the cell with relation to the top and bottom of the
culture dish) were compiled into live-motion movies using the imaging software
(MetaMorph 6.0, Universal Imaging Systems) showing virus dynamics inside of
live cells.
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c h a p t f r -i. appendix a n d glossary of t e r m s a n d Abbreviations
AIDS Acquired Immune Deficiency Syndrome
BAF Barrier to Autiointegration Factor
CA Capsid
CMV Cytomegalovirus
cPPT Central Polypurine Tract
EGFP Enhanced Green Fluorescent Protein
56FAM 56-carboxyfluorescein
GST Glutathione S-Transferase
HIV-1 Human Immunodeficiency Virus type 1
HMG High Mobility Group Protein
IN Integrase
Kap ex Karyopherin a
Kap P Karyopherin P
LTR Long Terminal Repeat
MA Matrix
MBP Maltose-Binding Protein
MLV Moloney Leukemia Virus
NC Nucleocapsid
NFAT-1 Nuclear Factor of Activated T-cells -1
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N L S Nuclear Localization Signal
NPC Nuclear Pore Complex
Nup Nucleoporin
PBL Peripheral Blood Lymphocytes
PBS Phosphate Buffered Saline
PCR Polymerase Chain Reaction
PIC Pre-integration Complex
PFA Paraformaldehyde
PR Protease
RRE Rev-Responsive Element
RT Reverse Transcriptase
SIV Simian Immunodeficiency Virus
TAR Tat-Activated Region
WGA Wheat Germ Agglutinin
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